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Summary 
 
Understanding cellular signaling pathways and their cross talk increasingly 
depends on the visualization of their spatio-temporal dynamics. 
This thesis investigates different factors influencing the performance of two 
FRET based protein kinase C (PKC) probes, KCP-1 and KCP-2. KCP-1 
consists of the truncated PKC substrate pleckstrin, sandwiched between two 
fluorescent proteins, EYFP and GFP2. KCP-2 is a shortened version of KCP-
1, missing the last 18 amino acids of the pleckstrin insert (the acidic loop). The 
EYFP/GFP2 emission ratio of KCP-1 increases upon phosphorylation, while it 
decreases in KCP-2. Both probes are reversible. 
We examined the influence of linker length, charge distribution in particular 
domains of the probe, and fluorophore dimerization on probe performance. 
Different FRET pairs, including novel fluorescent proteins and novel labeling 
techniques, were tested in an effort to vary and optimize the spectral 
properties of KCP probes. 
Both probes, KCP-1 and KCP-2, were shown to be sensitive to elongation in 
their N-terminal linker region. The signal amplitude of the probe was 
diminished with increasing linker length. Shortening of the same linker region 
reduced probe performance, although not to the same extent as elongation. 
This demonstrated the importance of linker length for proper orientation of the 
fluorophores in the probe molecule. 
Any changes in the N-terminal PH domain of the pleckstrin insert, for example 
shortening or replacing basic amino acids with uncharged or acidic residues, 
had severe impact on probe performance. The direction of the KCP-1 signal 
was reversed, showing a decrease instead of an increase after 
phosphorylation. The reversal of signal in KCP-1 probes reflects that specific 
interactions between the PH domain and the acidic loop are crucial for probe 
performance. In KCP-2, the impact was less striking, although the signal was 
reduced. 
Abolishing the fluorescent proteins' ability to dimerize, led to strongly reduced 
KCP-2-like signals in both probes. This is the first time that fluorophore 
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dimerization was shown to be essential for the mechanism of action of a 
genetically encoded sensor. 
  
Based on this data, we propose the following models for the mechanism of 
these PKC probes: 
In unphosphorylated KCP-2, dimerization of fluorophores serves as a clamp, 
pulling the two fluorophores together to a closed, quasi cyclized conformation. 
Phosphorylation of the probe leads to a more open conformation, increasing 
the average distance between the two fluorophores. This results in a decrease 
of FRET efficiency after phosphorylation.  
Two interactions determine the mechanism in KCP-1. Again, the dimerization 
of the two fluorophores serves as a clamp, pulling the fluorophores to close 
proximity. An additional interaction between the PH domain and the acidic 
loop changes the relative orientation of the transition dipole moments in the 
probe, resulting in a decreased initial FRET efficiency, compared to KCP-2. 
Phosphorylation of the probe imposes a strain on the intramolecular 
architecture that rearranges the transition dipoles, leading to an increase in 
FRET efficiency.  
The need for a molecular clamp, dimerization of fluorescent proteins in KCP-1 
and KCP-2 probes, within the molecule explains why probes containing new 
monomeric fluorescent proteins or other labels based on full sized proteins did 
not yield functional sensors. Using the small fluorophore FlAsH, however, we 
were able to create a smaller sized PKC probe. This probe will allow NMR 
experiments and structural analysis of a FRET probe for the first time. 
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Zusammenfassung 
 
Die Untersuchung zellulärer Signalwege und deren Wechselwirkungen 
bedient sich verstärkt Methoden zur Visualisierung räumlicher und zeitlicher 
Dynamik. 
In dieser Dissertation werden verschiedenen Faktoren untersucht, die die 
Leistungsfähigkeit zweier auf FRET basierender Sensoren  für Protein Kinase 
C beeinflussen (KCP-1 und KCP-2). 
KCP-1 besteht aus einer verkürzten Form des PKC Substrats Pleckstrin und 
den fluoreszenten Proteinen, EYFP und GFP2, die an den N- bzw. den C-
Terminus von Pleckstrin gesetzt wurden. KCP-2 ist eine verkürzte Version von 
KCP-1, bei der die letzten 18 Aminosäuren des Pleckstrins („acidic loop“) 
entfernt wurden. Das Verhältnis der Emissionen von EYFP und GFP2 nimmt 
zu, wenn KCP-1 phosphoryliert wird, während es bei KCP-2 abnimmt. Beide 
Sensoren sind komplett reversibel. 
Wir haben den Einfluss der Länge von verbindenden Sequenzen, von 
Ladungsverteilungen in bestimmten Domänen des Sensors, und von der 
Dimerisierung der Fluorophore untersucht. Die Verwendung neuer 
fluoreszenter Proteine und Markierungstechniken wurde untersucht, um die 
spektralen Eigenschaften in KCP Proben zu optimieren und zu variieren. 
Beide Sensoren, KCP-1 und KCP-2, zeigten veränderte Signalamplituden, 
wenn ihre N-terminale Verbindungsregion verlängert wurde. Mit zunehmender 
Länge der eingefügten Sequenz nahm die Amplitude des Signals ab. Eine 
Verkürzung der gleichen Region hatte einen ähnlichen Effekt, wenn auch 
weniger stark ausgeprägt. 
Dies zeigt die Bedeutung der Länge von Verbindungssequenzen für die 
richtige Orientierung der Fluorophore im Sensor-Molekül. 
Jede Veränderung in der N-terminalen PH-Domäne, z.B. Verkürzung der 
Domäne oder der Austausch basischer mit neutralen oder sauren 
Aminosäuren, hatte einen großen Einfluss auf das Verhalten der Sensoren. 
Die Richtung des KCP-1 Signals kehrte sich um. Anstelle eines ansteigenden 
Verhältnisses der EYFP/GFP2 Emissionen, wurde jetzt ein abnehmendes 
gemessen. Die Umkehrung des KCP-1 Signals verdeutlicht, daß durch die 
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Mutationen eine spezifische Bindung zwischen der PH-Domäne und dem 
„acidic loop“ zerstört wurde. In KCP-2 war der Effekt von Mutationen in der 
PH-Domäne weniger ausgeprägt, aber die Signalamplitude war deutlich 
herabgesetzt. 
Wurde die Dimerisierung der fluoreszenten Proteine verhindert, führte dies zu 
einem stark reduzierten Signal mit KCP-2-ähnlichem Verlauf. Die ist das erste 
mal, dass gezeigt werden konnte, dass die Dimerisierng für die Funktion eines 
genetisch kodierten Sensors essentiell ist. 
 
Ausgehend von diesen Daten, schlagen wir den folgenden Mechanismus für 
die Funktion der KCP Proben vor: 
Im unphosphorylierten KCP-2 Molekül wirkt die Dimerisierung der 
fluoreszenten Proteine wie eine Klammer, die diese zusammenhält und zu 
einer quasi-zyklischen Struktur führt. Die Phosphorylierung erzeugt eine 
offene Konformation, mit einem vergösserten durchschnittlichen Abstand der 
Fluorophore. Dies verringert die FRET-Effizienz nach der Phosphorylierung. 
In KCP-1 sind zwei Wechselwirkungen für den Mechanismus verantwortlich. 
Die Dimerisierung der beiden Fluorophore wirkt wieder als Klammer, die die 
Fluorophore näher zusammen zieht. Die zusätzliche Wechselwirkung 
zwischen der PH- und der DEP-Domäne sorgt allerdings für eine andere 
Orientierung der Übergangsdipolmomente der Fluorophore, welches die 
anfängliche FRET-Effizienz im Vergleich zu KCP-2 herabsetzt. 
Durch die Phosporylierung wird eine zusätzliche Spannung in das Molekül 
eingeführt, die für eine Reorientierung der Übergangsdipolmomente und einer 
vergrößerten FRET-Effizienz führt. 
Die Notwendigkeit einer molekularen Klammer innerhalb des Moleküls, wie 
zum Beispiel die Dimerisierung der Fluorophore, erklärt, weshalb Sensoren 
mit neuen monomeren Fluorophoren oder Markierungstechniken nicht 
funktionell waren. 
Mit dem kleinen Fluorophor FlAsH gelang es, einen neuen PKC Sensor zu 
entwickeln, der klein genug ist, um zum ersten Mal NMR Strukturstudien an 
einer auf FRET basierenden Probe durchzuführen. 
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1 Aims of the Thesis 
 
All processes in living organisms are governed by a complex signaling 
machinery. While it is possible to elucidate the interaction of individual 
components in vitro, their dynamics in time and space can only be studied in 
vivo. Fluorescence is ideally suited for investigation of biochemistry in living 
cells, as it is noninvasive and the necessary equipment is available in most 
laboratories. However, only a limited number of fluorescent sensors is 
available, probing protein-protein and protein-lipid interactions, changes in 
second messenger concentration or in local environment, e.g. PH or ion 
concentration. 
The aim of this thesis is to gain a better understanding of the mechanism of 
action of two previously published PKC probes; to increase the range of 
fluorophores that can be used in the probe; and to reduce to the size of the 
probe, to enable structural analysis. Thorough understanding of the 
mechanisms will allow development of improved versions of the existing 
probes. The lessons learned can be applied to the development of new 
probes. 
Specifically, the impact of linker length, the influence of inter-domain 
interactions and the importance of fluorophore dimerization, on probe 
performance is addressed. 
In addition, we explore the potential of hybrid methods, combining genetically 
encoded tags with chemical fluorophores, for the design of new sensors 
based on novel FRET pairs. The reduced molecular size of some of these 
probes will for the first time allow following conformational changes of a FRET 
probe by NMR. 
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2 Introduction 
 
2.1 Cell signaling 
2.1.1 Overview 
 
Understanding the complex networks underlying cell signaling increasingly 
relies on probes that visualize those processes in vivo. While in vitro 
experiments have provided a wealth of information, in vivo experiments 
provide a more realistic model of processes in the complex environment of a 
living cell. Cellular signaling networks are comprised of many different, 
interacting components. In order to understand the complex spatio-temporal 
dynamics of cell signaling, we need to follow as many components as 
possible at the same time. Fluorescent probes are useful tools for such an 
undertaking. There are a great variety of different colors, which are easily 
applied in many cell and tissue types and can be used to study cell biology 
and biochemistry in living cells. 
In this thesis, we examine how existing probes function in order to understand 
the mechanism of action underlying these probes. Based on two existing 
protein kinase C (PKC) probes, KCP-1 and KCP-21,2, we study the effect of 
dimerization, charge distribution and linker length on these probes. We also 
examine the possibility of using different labeling systems for probes, 
increasing the applicability of the probe in wider areas of the optic spectrum.  
We will first introduce protein kinase C and pleckstrin, followed by an overview 
of the physical basis of fluorescence and conclude with an overview about 
fluorescent labeling methods.  
2.1.2 Protein kinase C 
 
F. A. Lipmann and P. A. Levene at the Rockefeller University (New York) first 
identified the covalent attachment of a phosphate group to either serine or 
threonine residues of proteins in 1932 3. The first protein kinase to be found 
responsible for reversible phosphorylation was glycogen phosphorylase 
kinase in 1955 4-6. In the late 1960s, protein kinase A (PKA) was first 
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described7, followed by protein kinase G (PKG) in the 1970s8. In 1977, Y. 
Nishizuka et al first identified a protein kinase that seemed to be constitutively 
active and did not require more than Mg2+ (it was therefore named PKM)9-13. 
They hypothesized that they had found an active proteolytic fragment, which 
had lost its auto-inhibitory element. In 1979, they identified the pro-enzyme 
and found that it was activated by membrane phospholipids, in particular 
phosphatidylserine (PS). They also observed that it was activated by the Ca2+-
dependant protease calpain and therefore named it protein kinase C 
(PKC)14,15. 
 
The PKC family is currently one of the most thoroughly studied group of 
enzymes with more than 43000 papers discussing different aspects of its 
function, structure, regulation and implications in diseases. PKCs belong to 
the superfamily of protein kinases A, G and C (AGC superfamily) and mediate 
many signals resulting from the generation of second messengers by lipid 
hydrolysis. 
PKCs are involved in many key cellular processes. These include regulation 
of cell growth16-19 and cell differentiation18-22, gene expression23, early 
development24-26, apoptosis27-30, regulation of cell-matrix contacts31,32 or 
protection from cardiac ischaemia33-38. 
Seeing that PKCs are involved in all these pathways, it is not surprising that 
they have been implicated in many physiological functions and diseases. 
Examples include control of brain damage in stroke patients39,40, ageing of the 
brain41, neural plasticity and learning42, drug addiction43, hypertension44, 
repair of intestinal injuries45, type II diabetes46,47, arteriosclerosis38 and 
cancer48,49. 
 
PKCs are serine/threonine kinases and are represented in all eukaryotes. 
Twelve different isoenzymes have so far been described in the human 
genome. They can be classified in three groups: conventional PKC isoforms 
(cPKC), novel PKC isoforms (nPKC) and atypical isoforms (aPKC)50. 
Conventional PKCs, PKC-α51,52, PKC-βI51-53, PKC-βII51-53 and PKC-γ51,52, are 
activated by diacylglycerol (DAG) and Ca2+. Novel PKCs, PKC-δ54, PKC-ε54, 
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PKC-η55 and PKC-θ56 are DAG sensitive but do not respond to calcium. 
Atypical PKCs, PKC-ζ54 and PKC-ι57, neither respond to DAG nor to calcium. 
PKC proteins consist of a single polypeptide chain subdivided into the 
regulatory N-terminal region and the catalytic C-terminal region. Four 
conserved domains can be identified, C1 and C2 and the kinase domain, 
which is subdivided into C3 and C4, representing the ATP-binding and 
substrate binding lobes of the kinase (Fig. 2.1)58. 
 
Fig. 2.1 Schematic representation of the conserved domains in PKCs 
The C-terminal catalytic domain is conserved in all PKC subfamily members and is inhibited 
by the pseudosubstrate domain (red). The N-terminal regulatory domain differs structurally 
and functionally. Conventional isoenzymes contain a tandem C1 domain that binds DAG or 
phorbol esters and a C2 domain that binds to PS (Ca2+ dependent). Novel isoenzymes 
contain a C2-like domain that is not able to bind Ca2+. Atypical isoenzymes contain neither 
functional C1 nor C2 domains. Adapted from59,60.  
 
The pseudosubstrate (red in Fig. 2.1) domain binds to the kinase region and 
auto-inhibits the enzyme60,61. The pseudosubstrate sequence retains the 
hallmarks of a PKC phosphorylation site (several basic residues around the 
phosphorylation site62), but has an alanine at the predicted serine/threonine 
phosphorylation site: 
N'-K108-F109-A110-R111-K112-S113-T114-R115-R116-S117-R118-L119-C'  
(pleckstrin phosphorylation site63) 
N'-R19-F20-A21-R22-K23-G24-A25-L26-R27-Q28-K29-N30-C'  
(PKC pseudosubstrate60) 
Within the pseudosubstrate region, Ala25 is crucial. Mutation of Ala25 to serine 
converts the pseudosubstrate region into a potent substrate. The 
pseudosubstrate has to be removed from the kinase core for activation of 
PKC64,65. 
 
The C1 domain (blue in Fig. 2.1) binds DAG through a Cys-rich motif, which is 
duplicated in most enzymes58,66,67. This domain is responsible for strong over-
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activation of PKC by phorbol esters. It binds phorbol ester over two orders of 
magnitude tighter than DAG68. Phorbol esters can replace DAG for strong 
PKC stimulation: not only do they bind tighter to the C1 domain, but they are 
also metabolized slowly, prolonging their effect69,70. DAG and phorbol esters 
serve as hydrophobic anchors, recruiting PKC to the plasma membrane. 
 
The C2 domain (yellow in Fig. 2.1) contains, in conventional isoenzymes, the 
Ca2+ binding site. It contains a recognition site for acidic lipids and is 
responsible for Ca2+ dependent membrane targeting71. In nPKCs the Ca2+ 
binding site is inactive, but there is evidence for the C2 domain of PKC-δ 
being a protein interaction site72. However, in all PKCs the C2 domain of is 
responsible for lipid binding73,74. C1 and C2 domains can also be found in 
proteins other than PKC75-77. Some C1 domain containing proteins, which are 
not PKCs, are phorbol ester responsive as well. This has to be considered 
when observing effects after phorbol ester stimulation,  especially when 
observing proteins that might be regulated by PKC themselves, such as the 
C1-containing protein families of chimaerin78 and Munc79. 
Domains C3 and C4 form the kinase region (green in Fig. 2.1), where C3 
binds ATP and C4 the substrate80. PKC typically phosphorylates serine and 
threonine residues in a basic sequence, but it has less sequence specificity 
than PKA, for example81.  
The regulatory and catalytic regions are connected by a hinge that becomes 
proteolytically labile when the enzyme is membrane bound82. Cleavage of the 
hinge results in the constitutively active kinase PKM9-13. 
 
PKC is activated by many signals in cells, an increased amount of DAG in the 
membrane being the best described one. The inital pathway for DAG 
production is the cleavage of phosphatidylinositol 4,5-bisphosphate (PIP2) by 
phospholipase C (PLC), resulting in formation of soluble inositol 1,4,5-
trisphosphate (IP3) and membrane-bound DAG. Soluble IP3 leads to an 
increased Ca2+ level, which in turn drives localization of cPKCs to the 
membrane, where interact with DAG now present at elevated levels83,84. PLC 
itself is activated by many effectors, for example by binding to a G protein-
coupled, serpentine or tyrosine-kinase receptor (Fig. 2.2). 
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The hydrolysis of other phospholipids, namely phosphatidylcholine (PC), is 
also known to produce DAG (Fig. 2.2), although at a slower rate than in the 
pathway through PLC and PIP2 breakdown85,86. Phospholipase D (PLD) 
degrades PC to phosphatidic acid (PA), which is then de-phosphorylated to 
DAG by phosphohydrolase (PAP). This appears to be responsible for 
sustained activation of PKC, which is important for the longer responses, for 
example required during cell proliferation and differentiation61,70,87,88. 
Fig. 2.2 Schematic illustration of PKC activating signals 
Agonist-binding to G protein-coupled receptors (GPCR) or receptor tyrosine kinases (RTK) 
activates phospholipase C (PLC), which hydrolyses phosphatidylinositol 4,5-bisphosphate 
(PIP2) to inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 elevates intracellular 
calcium levels, protein kinase C is recruited to the membrane, where it binds to 
phosphatidylserine (PS) and DAG and is activated. Stimulation of GPCRs or RTKs can also 
lead to activation of phospholipase D (PLD), which hydrolyses phosphatidylcholine (PC) to 
phosphatidic acid (PA). PA is subsequently de-phosphorylated by phosphohydrolase (PAP) to 
DAG. Modified from61,70 
 
The activation of cPKCs and nPKCs is regulated by two mechanisms: 
phosphorylation of the enzyme itself and allosteric binding of cofactors that 
remove the pseudosubstrate from the substrate-binding site. 
Inital phosphorylation of PKCs is regulated by the phosphoinositide-
dependent kinase PDK-189-92. PDK-1 is generally involved in phosphorylating 
AGC superfamily protein kinases in their catalytical loop93,94. It consists of a 
kinase domain and a phosphatidylinositol 3,4,5 triphosphate-binding pleckstrin 
homology domain95,96. In PKA, this phosphorylation has been shown to be 
important for aligning the catalytic site of the enzyme properly97. According to 
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structural modeling, phosphorylation serves the same function in PKC-α and 
PKC-β98. The PDK-1-dependent phosphorylation of the activation loop in 
cPKCs, nPKCs and aPKCs is followed by rapid additional phosphorylation 
events, partly autophosphorylations in C-terminal regions99-102. These 
phosphorylations help lock the enzyme in its active conformation, although the 
exact order and requirement for PDK-1 independent phosphorylations 
remains to be established103. Phosphorylation does not activate the enzyme 
itself, but it is required for catalytic competence in cPKCs and nPKCs. 
Activation without previous phosphorylation is impossible. In contrast, 
phosphorylation directly activates aPKCs. 
Membrane localization and interaction with DAG are crucial for full activation 
of cPKCs and nPKCs. cPKCs are recruited to the membrane by interaction of 
the C2 domain with Ca2+ and anionic phospholipids. This interaction enhances 
binding to DAG at the membrane104-108. 
The active, membrane-bound enzyme efficiently phosphorylates its 
substrates. Additional regulatory mechanisms include interaction with PKC 
binding proteins109. These proteins can be subdivided into those that are also 
substrates (STICKs: substrates that interact with C-kinase)110,111; scaffolding 
proteins (RICKs: receptors for inactive C-kinases)112 that can restrict 
membrane and substrate access prior to PKC activation; and complexes, that 
can control substrate access after PKC activation (RACKs: for active C-
kinases)113-116. Localization of the PKC through targeting sequences 
(NLS/NES) is also important for isoenzymes specificity117. 
 
2.1.3 Pleckstrin  
 
Several PKC probes have been developed based on different PKC substrates 
in cells118-121. The probe used in this thesis is based on pleckstrin, the major 
substrate of PKC in platelets and leukocytes122-129. Pleckstrin (platelet and 
leukocyte C kinase substrate) is a rational template for a PKC probe, as it is 
absent from all other cells and is therefore not likely to interfere with signaling 
in other cells. In addition, it has been shown in NMR experiments to undergo 
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conformational changes upon phosphorylation (Sattler group, EMBL 
Heidelberg, unpublished results). 
Pleckstrin is phosphorylated at three phosphorylation sites by PKC. The 
phosphorylation sites lie between a PH and a DEP domain (Fig. 2.3) and 
consists of two serines and a threonine (N'-KFARKSTRRSIRL-C', 
phosphorylation sites in bold)63,130-133. 
Phosphorylation leads to translocation from the cytosol to the membrane in 
about 50% of pleckstrin molecules, which also depends on 
guanosinetriphosphate (GTP) binding proteins in platelets134. A clear function, 
however, has not been determined for pleckstrin in platelets. Activation of 
pleckstrin triggers cytoskeleton/membrane association134. There is evidence 
that pleckstrin interacts with Gβγ and phosphatidylinositol kinases after 
activation135,136 and its activation correlates with secretion of granule contents 
of platelets124. 
 
Fig. 2.3 Domain architecture of pleckstrin 
Pleckstrin consists of two PH domains, one N-terminal and one C-terminal, than enclose the 
PKC phosphorylation site and a DEP domain. 
 
In possessing two PH and the DEP domains, pleckstrin contains two modules 
that are found in many signaling molecules137-139. The PH (Pleckstrin 
homology domain) was first discovered in pleckstrin and is particularly 
common in kinases and GTPases. They are diverse in sequence, but have a 
conserved three dimensional fold. It consists of a 7-stranded β sandwich 
capped by an α-helix140. The N-terminal PH domain of pleckstrin was one of 
the first PH domain structures solved141. It was shown to bind liposomes 
containing phosphatidylinositol-4,5-bisphosphate (PIP2)142,143, suggesting a 
membrane targeting function of PH domains. The binding for PIP2 was shown 
to be mediated by a positively charged face of the PH domain that consists of 
three "variable loops". These loops are the most variable part in length and 
sequence within the family of PH domains137,144. These variable loops and 
their positively charged face bind to the polyphosphorylated inositol rings of 
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different phosphoinositides with weak or high affinity. Other examples include, 
the PH domain at the N-terminus of phospholipase C-δ, which binds PIP2 and 
inositol 1,4,5-trisphosphate (IP3)145,146 or the PH domain of protein kinase B 
(PKB), which binds equally well to phosphatidylinositol 3,4,5-triphosphate 
(PIP3) or to phosphatidylinositol 3,4-diphosphate147,148. A large number of PH 
domains, however, bind phosphoinositides or inositol phosphates only with 
low affinity and poor specificity149. In a qualitative filter binding assay, 
comparing binding of different PH domains to multiple phosphoinositides (PI), 
Kavran et al. demonstrated that PH domains from β-adrenergic receptor 
kinase β1, spectrin, Ras-GAP, pleckstrin (N-PH) and diacylglycerol kinase- β 
bound to every PI tested in the assay. Both PH domains of pleckstrin, N-PH 
and C-PH, are able to bind the G-protein heterodimer Gαβ in vitro150. 
Mutational analysis of this interaction showed that the protein binding site of 
N-PH and C-PH are located within the first 30 amino acids of the PH domain. 
The DEP domain was first discovered in signaling proteins like disheveled, 
Egl-10 and pleckstrin (hence the name DEP domain), but it is also present in 
certain kinases and regulators of G-protein signaling151. DEP domains are 
usually present as a single copy, only few proteins contain more than one 
DEP domain152,153. Little is known about its function, but it has been 
suggested to be involved in targeting of signaling molecules to the plasma 
membrane154,155. 
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2.2 Fluorescence and fluorescent in vivo labeling 
2.2.1 Fluorescence and Fluorescence Resonance Energy Transfer 
 
Fluorescence phenomena are caused by changes of the electronic distribution 
in molecules after irradiation with electromagnetic waves. An electron is 
excited to a higher energy level by absorption of a photon, and relaxes back to 
the ground state by emission of a photon with a longer wavelength. The 
energies needed for this are about 100 kJ/mol, which corresponds to 
wavelengths in the visible and ultra violet region of the spectrum156,157. 
In the quantum model, electrons in a molecule can occupy only discrete 
energetic states. The electron does not have access to a continuous energy 
landscape, but only to certain energetic states 156,157. 
 
Fig. 2.4 Jablonski diagram 
A Jablonski diagram is a simple schematic illustration of energy levels involved in absorption, 
fluorescence and phosphorescence. Electrons can be excited from ground state to higher 
electronic states by absorption of photons. Energy can be lost in a non-radiative way through 
vibrational relaxation or be emitted as photons of a lower wavelength (fluorescence). Modified 
from156.  
 
Transitions between energy states with different principal quantum numbers 
are allowed in fluorescence, but those with a change of the angular 
momentum are forbidden. As the ground state is devoid of an angular 
momentum, only transitions to other singlet states are allowed. Transitions 
with changes of angular momentum (intersystem crossing) have a very low 
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probability and give rise to the phenomenon of phosphorescence. The 
different energy levels are usually depicted in a Jablonski diagram (Fig. 2.4). 
Transitions only occur when light with the wavelength λ, corresponding to the 
energy difference of the exited and the ground state, is used. This is given by 
the Planck equation: 
 λν
hchEE groundexited ==−  (Eq. 1),  
where h is the Planck constant and v the frequency.  
 
In atomic spectra, electronic transitions give rise to very sharp bands in the 
spectrum. In larger molecules, the energy levels of the excited electronic 
states are modulated by the vibrational levels of the nuclei. Large molecules 
have a large number of different vibrational states, which leads to a broad, 
almost continuous distribution of energy levels and a smooth spectrum with no 
resolved bands that can be attributed to individual transitions.  
Typically, the fluorescent molecule sits at the lowest energy vibrational state 
before it is excited. From there, it can absorb light to reach one of the 
vibrational states of the first excited electronic energy level. The molecule 
subsequently decays to the lowest vibrational level of the excited state without 
emission of photons. The relaxation to one of the vibrational levels of the 
ground state is coupled to the emission of a photon. Since part of the energy 
is already dispersed in non-radiative processes, the emission wavelength is 
usually higher then the excitation wavelength (the difference between 
excitation and emission wavelength is called Stokes-Shift)156,157. 
The electron stays in the excited state for some time before it relaxes back to 
the ground state. During this fluorescence lifetime τ0, the excited molecule can 
transfer its energy to a neighboring molecule. This so called fluorescence 
resonance energy transfer was first described by V. T. Förster in 1948158. The 
transfer is based on a long range dipole-dipole interaction. The typical range 
of those interactions is 2-10 nm, which makes it ideally suited for distance 
measurements at the scale of biological macromolecules and complexes159. 
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The rate of energy transfer can be derived as follows: 
6
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t τ  (Eq. 2), 
where τD is the lifetime of the excited state of the donor in the absence of the 
acceptor and r is the distance between the fluorophores. As expected, the 
distance has a strong influence on the transfer rate. As the transfer rate 
scales with 1/r6, a doubling of the distance reduces the transfer rate 64 times. 
The Förster Radius, R0, summarizes other factors influencing the transfer 
rate: 
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The refractive index n is a measure for the shielding of transition dipole 
interactions by the solvent. κ is a factor that describes the relative orientations 
of the transition dipoles for the excitation. It is maximal for collinear transition 
dipoles κ=4 and minimal for perpendicular transition dipoles κ=0. For a 
mixture of molecules with random relative orientations due to rotation diffusion 
one can assume κ=2/3. The integral describes the spectral overlap of the 
acceptor absorbance spectrum ε(λ) and the donor fluoresce intensity FD(λ). A 
large overlap between the two spectra is essential for an efficient FRET. 
Since the transfer rate itself is difficult to measure directly, it is convenient to 
calculate which percentage of photons will be transferred to the acceptor for a 
given rate kt,. This property is called FRET efficiency E: 
tD
t
k
kE += −1τ (Eq. 4) 
This can be rearranged to: 
66
0
6
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RE +=  (Eq. 5) 
The Förster radius is therefore the distance, at which half of the energy is 
transferred to the donor. 
 
Several methods are commonly employed to measure FRET efficiency. They 
can be combined with conventional and confocal microscopes to measure 
spatially resolved FRET efficiencies in cells or other biological sample159,160. 
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The first way of detecting FRET is measuring an increase in the acceptor 
fluorescence upon donor excitation (sensitized emission)161. This seems to be 
the most straightforward method of measuring FRET but has drawbacks in 
practice. The emission spectra of most fluorophores have long tails towards 
longer wavelengths, which makes it difficult to separate donor and acceptor 
emission completely (bleed-through). The overlap of the emission spectra has 
to be experimentally determined and corrected for in the evaluation of the data 
(unmixing). 
Measuring the increase in donor fluorescence after photo-bleaching of the 
acceptor is another method of detecting FRET (acceptor photo-
bleaching)161,162. 
The difference between donor emission before (FDA) and after (FD) selective 
bleaching of the acceptor is a direct measure for the percentage of excitation 
energy transferred to the acceptor: 
D
DA
F
FE −=1  (Eq. 6) 
The emission spectrum of the acceptor usually does not extend to shorter 
wavelengths of the donor spectrum, spectral overlap is therefore a lesser 
problem in this method. The main disadvantage is that the method is difficult 
to apply quantitatively in living cells, because of the long times required for the 
complete bleaching of the acceptor. It is a reliable method, if cells can be fixed 
without damaging the structures to be observed. It has to be considered, 
however, that even though bleaching destroys acceptor fluorescence, the 
acceptor might still quench some donor fluorescence as the chromophore 
itself remains intact. 
A third method of measuring FRET efficiencies is observing the decrease of 
donor fluorescence lifetime in the presence of the acceptor163,164. 
The fluorescence lifetime τD depends on the rate of decay due to radiative (kr) 
and non-radiative (knr) processes: 
kt =τD-1=kr+knr (Eq. 7) 
kt is the total decay rate. 
In the absence of an acceptor the fluorescence will decay with a characteristic 
rate. FRET adds another non-radiative decay rate to the total rate. The 
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fluorescence lifetime of the donor in the presence of the acceptor τDA is 
therefore smaller than in its absence (τD). 
This is related to the FRET efficiency: 
D
DAE τ
τ−=1  (Eq. 8) 
Life time measurements can be performed in several ways. The most 
straightforward is to use a pulsed laser source for excitation and measure the 
decay of fluorescence intensity directly. Since typical lifetimes are well below 
5 ns, this method has high demands on both, the pulsing laser and the time 
resolution of the detector. 
The lifetime can also be measured in the frequency domain. The sample is 
illuminated with a continuous wave laser and the intensity of the laser beam is 
modulated with a high frequency. The lifetime of the excited state leads to a 
phase shift between the modulation of the excited state and emission light. 
The main advantage of lifetime imaging is that it can be applied in living cells, 
since it has a high time resolution and does not require the long bleaching 
periods of the acceptor photo-bleaching method. Lifetimes are sensitive to 
other environmental factors like ionic strength, pH or hydrophobicity of the 
solvent. Those influences have to be considered when interpreting life time 
data. An additional caveat of life time imaging is that it provides no information 
about sensor concentrations. 
Another widely used approach, does not determine absolute FRET 
effciencies, but a relative change by following donor-acceptor ratios165-170. We 
used this approach to measure PKC activity in living cells in this. 
 
The applications of FRET in biology are wide spread171. Two main 
applications have emerged over the last decade. 
The first is the determination of protein-protein interactions in living cells. The 
resolution of a light microscope is normally limited to around 200 nm. This is 
enough to visualize co-localization of fluorescently labeled proteins in the 
same cellular substructure, but not to determine whether proteins bind to each 
other or not. FRET, on the other hand, is limited to distances smaller than 10 
nm, which corresponds to the distance of directly interacting or bound 
proteins. This has been used extensively in numerous biological systems to 
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verify the protein-protein interactions in vivo. Examples include elements of 
the COPI vesicle machinery172, glycosyltransferases173, G-protein-coupled 
receptors174, the EGFP receptor175 or cholera toxin176. 
A second area, in which the FRET principle is extensively used, is the 
development of probes to visualize biochemistry in living cells. Any change, 
binding of co-factors, de-/phosphorylation168, protease activity167,177 or 
receptor activation178 that changes the distance or orientation between two 
fluorophores might be detected by FRET. Classic examples are the so called 
cameleon probes165,166,179,180, developed to visualize the beginning, 
termination and spatial distribution of Ca2+ signaling events. They consist of 
ECFP and EYFP connected by calmodulin (CAM) and the calmodulin binding 
peptide of myosin light chain kinase (MLCKp). When the Ca2+ concentration 
rises, it binds to the CAM domain, which in turn binds to MLCKp. This change 
decreases the distance between CFP and YFP and leads to an increased 
FRET efficiency181-183. In principle the Ca2+ concentration could be determined 
inside living cells by comparing the FRET efficiency with those obtained from 
control experiments in vitro184,185. 
 
2.2.2 Fluorescent in vivo labeling of proteins 
 
Few different methods are available for fluorescent labeling of proteins in 
living cells. Attaching fluorophores to antibodies for specific labeling of 
proteins has been used for a long time on permeabilized cells. This method 
has profited from the development of Quantum Dots (QD). QDs are inorganic 
nanocrystals with very distinct fluorescence properties that can be attached to 
antibodies or streptavidin. Their size (10 to 30 nm when coated) prevents 
them from passing the membrane, their use is therefore restricted to 
permeabilized membranes or extracellular proteins186-188. A recent commercial 
development (Promega), is the so-called HaloTag®189,190. It is based on a 
modified prokaryotic hydrolase. The 33kD monomeric protein can be used for 
N- and C-terminal fusions. Ligands can be constructed that specifically react 
with active cysteine, amine or carboxy-groups in the Halo protein. They 
contain a linker region that ensures specificity of the covalent attachment to 
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the Halo protein. The functional region can be attached to a large number of 
molecules ranging from fluorophores to biotin and other affinity labels. 
Far more common for in-vivo labeling is the use of genetically encoded 
fluorescent proteins. Hybrid methods, combining a genetically encoded tag 
with small chemical dyes are becoming more widely used, combining the 
advantage of a genetic tag with the large variability of fluorescent dyes. 
 
The following paragraphs describe the methods for in vivo labeling of proteins 
used in this thesis. 
2.2.3 Fluorescent proteins 
 
The first fluorescent protein, the green fluorescent protein (GFP) from the 
jellyfish Aequorea Victoria, was purified in 1962 by Shimomura et al191. It took 
30 more years until the gene encoding GFP was cloned192 and it could be 
shown that expression in other organisms than Aequorea193,194 was possible.  
 
Fig. 2.5 Crystal structure of GFP 
A Crystal structure of wild-type GFP. The chromophore at the center of the β-barrel is shown 
in red. PDB no 1GFL.  
B Enlarged view of the fluorophore of GFP (red). The fluorophore consists of amino acids S65-
Tyr66-Gly67. 
C Enlarged view of the fluorophore of EGFP (red). In EGFP, Ser65 has been mutated to Thr. 
PDB no 1Q4A.  
 
The 27kD GFP protein folds into an 11-stranded β-barrel with an α-helix 
running along the axis (see Fig. 2.5 A) 195,196. The chromophore is formed by 
Ser65-Tyr66-Gly67 located in the central α-helix (see Fig. 2.5 B). 
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It forms post-translationally in a two stage oxygen-dependent cyclization 
reaction. No other cellular factors are needed for the maturation reaction. The 
half time of the maturation of wild type GFP (wtGFP) is 25-85 min. The 
chromophore is buried and well protected by the β-barrel structure of the 
protein. β-barrel folding occurs prior to the maturation of the chromophore and 
has a half time of about 10 min197. 
 
The spectrum of wtGFP is complex and broad. The excitation spectrum has a 
major peak at 395 nm and a minor peak at 475 nm. The emission maxima are 
at 508 and 503 nm, depending on the excitation198. The spectral properties of 
wtGFP are pH sensitive. 
The wtGFP sequence has been extensively mutated to reduce the limitations 
of wtGFP. The first widely used GFP variant was enhanced GFP (EGFP). In 
EGFP Ser65 was mutated to threonine (see Fig. 2.5 C)199. The mutation leads 
to an ionization of the phenol of the chromophore shifting the excitation 
maximum to a single peak at 490 nm with a 4-6 times increased intensity. The 
maturation is accelerated four times in the S65T mutant198. An additional F64L 
mutation in EGFP further increases the brightness of GFP and reduces the 
maturation time200. EGFP was codon optimized for a more efficient expression 
in higher eukaryotes, like mammals201. 
Many applications in biology require the use of multiple colors. A large number 
of spectral variants of GFP have been developed by different groups. 
Significantly red shifted variants can be produced by stacking an aromatic ring 
next to the phenolate ion of the chromophore. The most commonly used 
variant is EYFP, which contains the mutation T203Y. The excitation peak is 
shifted to 512 nm and the emission to 525 nm. Additional mutations in the 
periphery of the fluorophore increase the extinction coefficient (V68L) and 
accelerate folding (S72A)195. EYFP was shown to be sensitive to 
environmental influences like pH or chlorine ions, which was overcome by 
introducing an additional mutation (Q69M). The new variant, called Citrine has 
increased photostability and decreased pH and chlorine sensitivity202. Further 
mutations at the fluorophore or surrounding region have created several more 
colors based on the wtGFP from A. victoria. Examples include a cyan 
fluorescent protein (ECFP), which has an excitation maximum at 434 nm and 
   
Introduction   30 
an emission maximum at 475 nm203 or an even more blue-shifted protein, the 
blue fluorescent protein (BFP). Although it has interesting spectral properties 
(excitation at 380 nm and emission at 442 nm), its poor photostability and dim 
fluorescence make it rarely used198. Monomeric versions of EYFP and ECFP 
have recently been improved for faster folding and improved brightness204. 
Another desirable property in fluorescent proteins is a large Stokes shift for 
better separation of excitation and emission wavelength. Sapphire and GFP2 
are proteins that have this quality. Sapphire and GFP2 have an excitation and 
emission peak at 399 and 511 nm, respectively205,206. 
Despite the efforts of several groups, no protein further red shifted than YFP 
has been developed based on the A. victoria GFP. Work has therefore 
concentrated on finding new fluorescent proteins from other organisms that 
have are red shifted compared to GFP. DsRed, cloned from coral Discosoma 
species207, has been developed into a number of variants with desirable 
photo- and biochemical properties. The original DsRed has a strong tendency 
for tetramerization and matures very slowly (t1/2 ~10h)208, which renders it 
difficult to use for most applications. A monomeric version with an improved 
maturation time was developed by the Tsien laboratory, but it was five times 
dimer than the original DsRed and less photostable209. Extensive mutational 
screens have yielded a large number of improved variants with diverse 
spectral characteristics210,211. Promising variants found in this screens include 
the monomeric red shifted variants mPlum (590/649), mCherry (587/610) and 
mOrange (548/562)210. Several more FPs of other species were also 
described, including a monomeric orange FP (mKO) from the coral Acropara 
species212, MonsterGreen™ (Promega) from Montastraea cavernosa and 
AcGFP1 cloned from Aequorea corulescens (BD Bioscience). 
A whole family of proteins has been cloned from Anthozoa reef corals. 
Currently efforts are underway to produce monomeric variants and to increase 
maturation speed and brightness213. 
A number of photoactivatable (pa) and photoswitchable (ps) fluorescent 
proteins have been developed in the last few years. pa-GFP is essentially non 
fluorescent in its ground state, but can be irreversibly activated with a short 
pulse of 413 nm light214,215. pa-mRFP1 can be activated with a 380 nm light. 
ps-CFP and ps-CFP2 change their fluorescence maxima from 468 to 511 nm 
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upon UV-irradiation (The proteins are derived from A. corulescens not from A. 
Victoria)216,217. 
A fascinating development is the FP Dronpa, which can be switched from a 
non-fluorescent state to a green fluorescent state with 400 nm, but also 
switched off again with intense blue light (470-500 nm). Both processes are 
entirely reversible and repeatable218. The Kaede family of fluorescent proteins 
shows promising results for the development of efficient photoswitchable FPs, 
but have so far been hampered by tetramerization and low stability above 
30°C217,219,220. 
 
For FRET applications, the donor-acceptor pair should ideally fulfill several 
criteria in order to have a large Förster radius: The donor should have a large 
quantum yield, the spectral overlap should be as large as possible and the 
donor should have a large stokes shift to allow a selective excitation of the 
donor. For applications in tissues or living animals, FRET pairs should have 
long excitation and emission wavelengths and should be stable in two-photon 
excitation. For labeling of other proteins the FPs should be monomeric, 
although a weak dimerization can enhance the observed signal without 
changing the behavior of the tagged proteins (see this thesis). 
The donor/acceptor pairs with the best spectral properties at the moment are 
CyPet-YPet221 and GFP2-EYFP206. For applications, where an acceptor 
emission further red is desirable, the best pair currently seems to be cyan 
MiCy with orange mKO. Both were cloned from Acropara species. MiCy forms 
dimers, which makes it difficult to use in most application212. Experiments with 
other donors for mKO have not been reported so far. 
In the red region of the spectrum no satisfying donor/acceptor combination 
has been reported so far. GFP and DsRed form a good donor/acceptor pair 
with an R0 comparable to the common CFP/YFP pair222,223, but the strong 
tetramerization of DsRed is of disadvantage. Experiments using the new 
mRFP1 variants have not been reported so far210,211. Clearly the development 
of improved long wavelength FRET pairs is important for the application of 
FRET in tissue. 
 
   
Introduction   32 
Table 2.1 summarizes the spectral properties of several fluorescent proteins 
mentioned in this thesis. 
Name  Excitation
[nm]  (ε) 
Emission 
[nm] (QY) 
Brightness Photostability 
[sec] 
Oligomer-
ization 
BFP 382 (21) 448 (0.24) 5 ND weak dimer 
wt-GFP  395 (27.5) 
472 (7.5) 
504 (0.79) 21 ND weak dimer 
GFP2 396 (84) 510 (0.61) 51 ND weak dimer 
T-
Sapphire  
399 (44) 511 (0.6) 26 25 weak dimer 
ECFP 433 (28) 475 (0.45) 13 64 weak dimer 
CyPEt 435 (35) 477 (0.51) 18 59 weak dimer 
EGFP 488 (55) 508 (0.6) 34 174 weak dimer 
MiCy 472 (27) 495 (0.90) 24 ND dimer 
AcGFP1 475 (32) 505 (0.82) 27 ND monomer 
EYFP 514 (83) 527 (0.61) 50 60 weak dimer 
YPet 514 (43) 527 (0.62) 51 60 weak dimer 
Citrine  516 (77) 529 (0.76) 59 50 weak dimer 
mKO 548 (52) 559 (0.6) 31 122 monomer 
mOrange 548 (71) 562 (0.69) 49 9 monomer 
DsRed 558 (75) 583 (0.79) 60 ND tetramer 
mRFP1 584 (50) 607 (0.25) 12.5 6.2 monomer 
mCherry 587 (72) 610 (0.22) 16 96 monomer 
mPlum 590 (41) 649 (0.1) 4.1 53 monomer 
Table 2.1 Spectral properties of some fluorescent proteins  
ε is the absorption coefficient in mM-1cm-1, QY is the quantum yield. The brightness is the 
product of ε and QY in mM-1cm-1. The photostability is the time in seconds to go from en initial 
emission of 1000 photons/s to 500 with constant excitation intensity. This does not 
necessarily reflect the photostability under other conditions. ND = not determined. 
Source:210,212,224-226 and http://www.clontech.com/ 
2.2.4 Fluorescent labeling of proteins in living cells with AGT 
 
Specifically attaching small, chemically synthesized molecules is another way 
of efficiently labeling proteins in living cells. These methods have certain 
requirements to meet. The dye has to specifically recognize a tag and bind to 
it with high affinity. The tag should neither be too big, nor disturb the tagged 
proteins function and should not occur naturally in cells. In addition, the dyes 
should not be toxic for cells and pass the membrane easily. 
 
AGT labeling is based on the DNA repair enzyme human O6-alkylguanine-
DNA alkyltransferase (AGT)227,228. AGT plays an important role in cellular 
defense against alkylating agents by removing alkyl adducts at the O6-position 
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of guanine and covalently binding it to one of its cysteines. This prevents one 
of the most harmful lesions as it leads to GC→AT transition mutations, which 
are associated with mutagenic, toxic and carcinogenic effects229. The 
substrate specificity of AGT is relatively low since it readily reacts with O6-
benzylguanine (BG) derivatives. This property can be used for the labeling of 
proteins that are tagged with AGT. By synthesizing BG derivatives of 
fluorophores, these fluorophores can be irreversibly transferred to AGT and 
hence the protein of interest (Fig. 2.6). AGT labeling can be very specific and 
fast, but technically challenging. This enables labeling of a single AGT fusion 
protein with a wide range of different dyes230,231. AGT has been used for 
protein labeling as an alternative to GFP in anaerobic organisms232. 
 
Fig. 2.6 Covalent labeling of a protein of interest fused to AGT 
An O6-benzylguanine (BG) fluorophore derivative is recognized by AGT and readily 
transferred to a cysteine residue of the protein. The label is covalently bound and the reaction 
irreversible. 
 
2.2.5 Fluorescent labeling of proteins in living cells with FlAsH 
  
Arsenoxides are known to have a high affinity for thiols, including closely 
spaced cysteines. FlAsH, containing two arsenoxides, has a high affinity for 
four appropriately spaced cysteines. The rigid spacing of the two arsenoxides 
enables FlAsH to bind with high specificity to the small tetracysteine motif 
(TCM) introduced into proteins (Fig. 2.7 A). This approach was first introduced 
by Tsien et al. in 1998233. The tetracysteine motif has since been optimized for 
selective binding of FlAsH, higher fluorescence quantum yield and better 
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dithiol resistance, thereby reducing background labeling234. The best motif 
found so far consists of 12 amino acids with the sequence FLNCCPGCCMEP.  
 
Fig. 2.7 Fluorescent labeling of proteins in living cells with FlAsH 
A A protein encoding the tetracysteine motif (TCM) is labeled with FlAsH-EDT2. When binding 
to the TCM, the FlAsH becomes fluorescent. 
B Normalized spectra of the excitation (dashed line) and emission (solid line) of CHoxAsH-
EDT2, FlAsH-EDT2 and ReAsH-EDT2. 
C chemical structures of CHoxAsH-EDT2, FlAsH-EDT2 and ReAsH-EDT2. 
 
This labeling method, however, still has relatively high background235, 
especially when compared to genetically encoded fluorescent proteins or 
AGT. 
FlAsH is best isolated as a FlAsH-EDT2 adduct, which enters cells easily. 
FlAsH-EDT2 is practically non-fluorescent, but FlAsH bound to the TCM has a 
quantum yield of 0.4 (≥5x104 times more fluorescent as FlAsH-EDT2). The 
standard FlAsH has excitation and emission peaks at 508 and 528 nm, 
respectively. Other colors include ReAsH (excitation and emission maxima at 
593 and 608 nm, respectively) and CHoxAsH-EDT2 (excitation and emission 
maxima at 380 and 430 nm, respectively)236 (Fig. 2.7 B and C). 
FlAsH and ReAsH have been used in many applications, e. g. in FRET based 
assays to determine G protein-coupled receptor activation178, in correlative 
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fluorescence and electron microscopy237, for determination of protein age by 
multicolor fluorescence pulse-chase237,238 or in chromophore-assisted light 
inactivation (CALI)239,240. CHoxAsH has been used to a lesser extend as it is 
less bright and has lower photostability than the other two dyes. 
The key advantage of the FlAsH labeling method, compared to other labels 
such as FPs or AGT, is the small size of the tag. It has previously been 
shown, that the size of the tag used for the labeling of proteins, can influence 
the functionality of the tagged protein. S. Jacobs et al. showed that C-terminal 
tagging of the microtubule protein β-tubulin (Tub2) in S. cerevisiae resulted in 
nonviable haploid cells, while labeling with FlAsH did not affect protein 
function241. 
  
2.3 Fluorescent probes 
 
In recent years, an increasing number of probes, utilizing fluorescence as a 
detection marker, have been developed 160,242-244. In basic applications, the 
fluorophore is used as a marker for the tagged protein, monitoring 
appearance, localization or degradation of the protein. Inherent properties of 
fluorescent proteins or fluorophores can be used to detect changes in the 
concentration of PH or halides. SNARF is a red fluorescent fluorophore, 
whose emission depends on PH, that has been used for measuring local 
changes in PH inside cells245. Fluorescent proteins have also been employed 
for PH measurements246-248 and the yellow emission variant (YFP) is useful to 
follow Cl- flux in epithelial cells249. 
A simple way to follow dynamics in the cell, based on fluorescent tagging of a 
protein, is to observe domains that translocates upon activation. An example 
for this kind of biosensor is a GFP-tagged C1 domain of protein kinase C 
(PKC), which translocates to the plasma membrane upon increase of 
diacylglycerol (DAG) in the membrane250. Other examples include the PA 
binding domain of Raf251 or the pleckstrin homology domain (PH domain) of 
several proteins252-254, which all translocate to the plasma membrane upon 
their specific cue. 
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Many probes have been developed that are based on fluorescence resonance 
energy transfer (FRET, see 2.2.1) between a donor and an acceptor 
fluorophore. Some measure interactions between proteins, others detect 
changes in the intracellular concentration of second messengers. Changes in 
cGMP concentration were measured by change in FRET from ECFP to EYFP. 
The donor and acceptor fluorophores were fused to two different cGMP 
receptors (truncated cGMP-dependent protein kinase or cGMP-dependent 
protein kinase Iα) which both change their conformation upon cGMP 
binding255,256.  
Interactions between two proteins can be detected by fusing donor and 
acceptor fluorophores to the interaction partners. Transcription factor homo- 
and heterodimerization257, G-protein dissociation258 and other 
interactions170,259-264 have been visualized this way. Other probes are based 
on a substrates peptide , e.g. for kinases, sandwiched between a donor and 
acceptor fluorophore, that undergo conformational change upon 
phosphorylation by their respective kinase2,118-121,265. 
 
Understanding of how existing probes are working is essential for the 
improvement and development of new probes. Two PKC probes and a dual 
PKC/PKA probe have been developed in our lab1,2. This thesis intends to 
understand the mechanism of action of two of these probes, KCP-1 and KCP-
2, in order to improve existing probes and develop new sensors. 
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3 Materials and Methods 
 
3.1 Materials and equipment 
3.1.1 Chemicals and kits  
 
Standard chemicals were purchased from Sigma-Aldrich AG (Steinheim, 
Germany), Serva (Heidelberg, Germany) or Merck (Darmstadt, Germany) at 
the highest purity available. 
Bradykinin, 2-[1-(3-Dimethylaminopropyl)-5-methoxyindol-3-yl]-3-(1H-indol-3-
yl) maleimide (Gö6983) and Phorbol-12-myristate-13-acetate (PMA or 13-
acetate 4α-TPA, TPA) were purchased from CalBioChem (Eggenheim, 
Germany). 
Kits for DNA purification were purchased from Qiagen GmbH (Hilden, 
Germany).  
Competent cells (XL1-Blue Subcloning Grade Competent Cell) were bought 
from Stratagene (La Jolla, USA).  
3.1.2 Enzymes 
 
Enzymes for recombinant DNA work were purchased from New England 
Biolabs (Ipswich, USA), Stratagene (La Jolla, USA) or Fermentas (St. Leon-
Roth, Germany). 
3.1.3 Reagents and buffers 
 
Reagents and buffers were prepared according to standard protocols unless 
otherwise mentioned 266,267.  
3.1.4 DNA primers and oligonucleotides 
 
DNA primers and oligonucleotides were purchased from MWG Biotech GmbH 
(Ebersberg, Germany).  
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3.1.5 Plasmids 
 
The following standard plasmids were purchased from Clontech (Carlsbad, 
USA): pEGFP, pEYFP and pECFP. The vector containing pGFP2 was 
purchased from PerkinElmer Life and Analytical Sciences, Inc. (Boston, USA). 
 
The following plasmids were kind donations by the following people: 
 
GEhAGT-B-CaaX   A. Keppler, EMBL, Heidelberg, Germany 
pNuc-GEhAGT-B     A. Keppler, EMBL, Heidelberg, Germany 
AGT177    A. Keppler, EMBL, Heidelberg, Germany 
pET9d-Pleckstrin(1-221)   M. Sattler, EMBL Heidelberg, Germany 
pET9d-Pleckstrin(1-239)   M. Sattler, EMBL Heidelberg, Germany 
mCherry    R. Y. Tsien, UCSD, San Diego, USA 
mOrange    R. Y. Tsien, UCSD, San Diego, USA 
3.1.6 Bacteria 
 
E. Coli BL21 (DE) for protein expression 
E. Coli XL1blue for DNA amplification 
 
3.1.7 Cell lines 
 
HeLa CCL-2 (human)   LGC Promochem GmbH, Wesel, Germany 
N1E-115 (murine)    LGC Promochem GmbH, Wesel, Germany 
HEK-293 (human)   LGC Promochem GmbH, Wesel, Germany 
 
3.1.8 Cell culture and imaging  
 
Chemicals and solutions for cell culture were purchased from Gibco 
(Eggenstein, Germany). 
Transfection reagent, Fugene6, was purchased from Roche (Mannheim, 
Germany. 
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Cell dishes with glass bottoms were purchased from MatTek (Ashland, USA) 
and welled cover slides (LabTek) from Nunc (Wiesbaden, Germany). 
3.1.9 Microscopes and other equipment 
 
Leica AOBS SP2    Leica Microsystems (Heidelberg, Germany) 
 
Visitron System 
Zeiss Axiovert  Carl Zeiss Mikroskopiesysteme (Jena, 
Germany) 
CCD camera Coolsnap  HQ Photometrics, Roper Scientific, Inc. 
(Trenton, USA) 
Filter wheel system  Visitron Systems GmbH (Puchheim, 
Germany) 
 
FlAsH microscope set-up 
Zeiss Axiovert 135 Carl Zeiss Mikroskopiesysteme (Jena, 
Germany) 
 
Filters and dichroics Till Photonics GmbH (Gräfelfing,  
Germany) 
 
Fluorimeter Photon Technology International 
Quantamaster QM4/2000SE  
(PhotoMed GmbH, Seefeld, Germany) 
DNA spotter  
Virtek Chipwriter Compact Eurogentec (Seraing, Belgium) 
Pins: PTS/ PTLS 600 Point Technologies, Inc (Boulder, USA) 
 
Microinjection 
InjectMan NI2 micromanipulator Eppendorf (Hamburg, Germany) 
Femtotips II Eppendorf (Hamburg, Germany)  
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3.1.10 Software 
 
ImageJ      (http://rsb.info.nih.gov/ij/)   
     W. Rasband, NIH, Bethesda, USA 
Metamorph v6.2r4     Universal Imaging Corp., 2004 
Origin v6.1  OriginLab Corporation, Northampton, 
USA 
 
Fluorimeter Felix v1.41. 
3.2 Methods 
3.2.1 General methods 
 
DNA cloning was performed according to standard procedures266,267.  
Kits for purification of plasmid DNA, as well as for purification of PCR and 
restriction products, were used according to the protocol of the supplier.  
DNA sequencing was performed by EMBL genomics core facility.  
 
3.2.1.1 PCR 
 
PCR was performed in thin-walled 0.2 ml tubes. A standard PCR usually 
contained: 
- 
- 
- 
- 
50 to 100 ng of template DNA  
100 ng primer, 5' and 3', each 
250 µM dNTPs  
10x PfuTurbo DNA polymerase buffer 
2-3 U PfuTurbo DNA polymerase  
H2O up to a total of 50 µl 
 
Some PCRs contained a mix of 1-2 U Pfu polymerase and 1-2 U TAQ 
polymerase to increase amplification efficiency while ensuring proof-reading 
activity. 
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A typical PCR consisted of the following cycles: 
 
95 °C  –  5 min denaturing 
 
95 °C  –  30 s denaturing  
50 °C  –  45 s annealing  5 cycles 
72 °C  –  1 min extension 
 
95 °C  –  30 s denaturing 
55 °C  –  45 s  annealing  25 cycles 
72 °C  –  1 min extension 
 
72 °C  –  10 min  extension 
 
Annealing temperature was varied according to the melting temperature of the 
primers. Extension time was varied according to the expected size of the 
product. The last extension step was added for increased proof-reading.  
PCR products were analyzed on a 0.8-1.5% agarose gel, according to the 
length of the expected fragment. 
 
3.2.1.2 Introduction of point mutations 
 
a) Site-directed mutagenesis 
 
A single mutation can easily be introduced into an existing vector by using 
site-directed mutagenesis (see Fig. 3.1 A). Two primers, containing the 
desired mutation, and flanked by the correct and matching sequence, have to 
be designed. In a PCR, the plasmid is denatured to facilitate annealing of the 
primers. PfuTurbo DNA polymerase extends the mutagenic primers, resulting 
in nicked circular strands. The only difference compared to a regular PCR is 
the much longer extension time, as the whole plasmid has to be synthesized 
(calculate 2 min per kb DNA). 
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After the PCR, the restriction enzyme DpnI is added to the reaction mix for 1 h 
at 37°C. This enzyme digests the methylated, non-mutated parent DNA, while 
leaving the newly synthesized one intact. A small amount (usually 2 µl) of the 
circular, nicked dsDNA can be transformed into competent bacteria, where the 
nick will be repaired and the plasmid multiplied. 
 
Fig. 3.1 Introduction of point mutations 
Schematic representation of two methods to introduce point mutations into DNA 
A Site-directed mutagenesis: the mutation is introduced into a plasmid using two mutagenic 
primers and a PCR of the whole plasmid. 
B Introduction of mutations via three independent PCRs: the mutation is introduced by 
performing three PCRs with two mutagenic primers and two primers containing restriction 
sites for cloning.  
For a detailed description of the two methods, see 3.2.1.2. 
 
b) Introduction of mutations via three PCR steps 
 
Site directed mutagenesis should not be used if the primers introducing the 
mutation can anneal on several sites on the vector, introducing the mutation 
more than once. If this is the case, mutations can be introduced via three 
different PCRs (Fig. 3.1 B). This method is also recommended if restriction 
sites have to be introduced at the ends of the desired PCR product for further 
cloning.  
Four different primers have to be designed for this method. The first two are a 
sense primer at the 5'-end (S1) and a reverse primer at the 3'-end (R1) of the 
target DNA. These primers usually contain the restriction site, which is going 
to be used to clone the PCR product into the destination vector. 
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The second set of primers consists of a sense (S2) and a reverse (R2) primer 
that are complementary to each other and contain the single mutation. More 
than one point mutation can be introduced using this method; however with an 
increasing number of mutations, the risk of incorrect or no annealing 
increases.  
In two separate PCRs, two parts of the molecule are created, each containing 
the mutation. The PCRs use the same template, but PCR1 is performed with 
primers S1 and R2, while in PCR2 primers S2 and R1 are used. In PCR 3, the 
products of the previous two reactions are mixed with primers S1 and R1. This 
connects the two parts, yielding the full construct (see Fig. 3.1). 
3.2.1.3 Oligonucleotide ligation 
 
The easiest way to introduce short stretches of DNA is oligonucleotide 
ligation. Two complementary primers, coding for the desired insert and with 
sticky ends matching the appropriate restriction site(s), have to be designed. 
The primers are first dimerized by mixing 500 pmol of sense and reverse 
primer and heating them to 95°C for 5 min. The mixture is allowed to cool to 
room temperature. For the kinase reaction, 10 pmol DNA is mixed with 10 U 
of T4-Polynucleotide Kinase (T4-PNK) in a buffered solution containing 10 µM 
ATP. This mixture is incubated at 37°C for 40 min. T4-PNK is subsequently 
inactivated by heating to 60°C for 20 min. 
In order to ligate the dimerized DNA oligos into the target plasmid, 0.4 pmol 
DNA is mixed with 1 µl (usually between 0.3-0.6 µg DNA) of the previously 
digested plasmid DNA. T4-DNA ligase is added and the mixture left at room 
temperature for 30 min. Primers for oligonucleotide ligation have to be 
designed with sticky ends complementary to the appropriate target DNA 
sequence. The ligation can then be transformed into chemically competent 
bacteria. 
Chemically competent bacteria were prepared according to standard 
protocol266,267 or bought from Stratagene (La Jolla, USA). 
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3.2.1.4 Cell culture  
 
Cell cultures were maintained by Heike Stichnoth and cultured at 37°C and 
5% CO2. HeLa CCL-2 cells were cultured in DMEM with 10% FCS and 
Primocin; N1E-115 cells were cultured in high-glucose DMEM with 10% FCS 
and Primocin. HeLa CCL-2 and HEK-293 were subcultured twice a week; 
N1E-115 three times a week. 
3.2.1.5 Transient transfection of mammalian cells 
 
Cells were transfected at 40-60% confluency with 1 µg of total DNA using 
Fugene6 in Optimem, according to the protocol of the manufacturer. Cells 
were incubated at 37°C and 5% CO2 to allow for protein expression. 
Expression time was usually between 15 and 48 h. 
3.2.1.6 DNA spotting 
 
For parallel experiments with several different constructs on one microscope 
slide, small amounts of DNA were spotted on welled glass slides (LabTek 
chambers) together with transfection reagent. Cells could be seeded on these 
slides and imaged after attachment and protein expression. 
The spotting was performed by Holger Erfle (Mitocheck, EMBL Heidelberg). 
Lipofectamine (3.5 µl) was added to 4 µl Optimem with 0.4 M sucrose and left 
standing at room temperature for 5 min. DNA (1 µg) was added to the mix and 
incubated for another 15 min. Subsequently, 7.5 µl of an aqueous solution 
with 0.2% gelatin and 0.001% Fibronectin was added to the mix and, after an 
incubation of 15 min, spotted onto the slides with pins of diameter 600 µm. 
The arrays could be kept at 4°C for several weeks. 
For experiments, the slides were covered with a HeLa cell suspension in 
Optimem. Cells were imaged 20-24 h later allowing enough time for cell 
attachment and protein expression. 
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3.2.1.7 AGT labeling 
 
HeLa CCL2 cells were transiently transfected with DNA coding for one of the 
listed AGT-PKC probes (see 3.2.2.5 a). The AGT labelling dyes were 
prepared as 0.8 µM stock solutions in DMSO. Cells were incubated in HEPES 
buffer (115 mM NaCl, 1.2 mM CaCl2, 1.2 mM MgCl2, 2.4 mM K2HPO4·3 H2O, 
10 mM Glucose·1 H2O, 20 mM HEPES, pH 7.4) or Optimem containing 5 µM 
of the respective labelling dye for 5-15 min, washed with PBS buffer three 
times and kept at 37°C in medium until imaging. 
The non-cell permeable dye O6-benzylguanine-Cy3 (BG-Cy3) had to be 
microinjected for AGT labelling. These microinjections were performed by 
Antje Keppler (EMBL Heidelberg). BG-Cy3 was diluted in water to a final 
concentration of 30 µM and microinjected into cells. Cells were injected with 
50 hPa injection pressure for 0.8 sec by penetrating the cell surface with an 
injection capillary micropipette. For all dyes, imaging was only started 30 min 
after washing or microinjection, respectively. 
The BG-2-OH-nile red was synthesized by Shannon Black (EMBL 
Heidelberg), with the O6-benzylguanine-Cl precursor kindly provided by Maik 
Kindermann (EPFL, Lausanne, Switzerland). 
All other BG-dyes were kindly provided by Kai Johnsson (EPFL, Lausanne, 
Switzerland). 
3.2.1.8 FlAsH labeling 
 
HEK-293 cells were transiently transfected with DNA coding for one of the 
listed CFP/ FlAsH PKC probes (see 3.2.2.5 b). The cells were labeled with 
FlAsH 24-48 h after transfection, according to the following procedure237. 
FlAsH was synthesized by Andreas Schleifenbaum (EMBL, Heidelberg). 
FlAsH was first incubated with 12.5 µM EDT, giving FlAsH-EDT2. FlAsH-EDT2 
was then used at a final concentration of 1 µM in a (microscope) dish and 
cells were incubated for 1 h at 37°C in Hank's Balanced Salt Solution (HBSS: 
10 mM HEPES, 140 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl2 and 1 
g/L Glucose at pH 7.3). After incubation, unbound and non-specifically bound 
FlAsH was removed by a 10 min washing step with 200 µM EDT in HBSS. 
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Labeled cells were kept at 37°C in medium until imaging. 
FlAsH binding to the tetracysteine motif was destroyed by adding 5 mM 
British-Anti-Lewisite, (BAL, 2,3-dimercaptopropanol). BAL competes for FlAsH 
binding and removes FlAsH from the tetracysteine target sequence, rendering 
it non-fluorescent. Addition of BAL is necessary for calculation of FRET 
efficiency. The FRET efficiency is calculated by dividing the difference in 
ECFP (mCFP) fluorescence at its maximum (after BAL addition) and its 
minimum (start value ECFP) with the maximum value: 
max
max
ECFP
ECFPECFPFRET starteff
−= . 
3.2.1.9 Live cell imaging with wide field microscopy 
 
a) Wide field microscopy for PKC probes using GFP2 and EYFP 
 
Wide field microscopy was performed on a Zeiss Axiovert microscope with 
automatic stage and fast emission and excitation filter wheels. Images were 
recorded with a CCD camera using Metamorph software. Cell medium was 
replaced by HEPES buffer one hour before the experiments and. Cells were 
kept starving at 37°C and 5% CO2. The experiments were performed at 37°C 
in a heating chamber. 
Compounds for addition were prepared as 1000x stock solutions in DMSO or 
water according to the protocol of the supplier. The compounds were pre-
dissolved in 100 µl buffer before addition to the experiment. 
GFP2 in all KCP-1 and KCP-2 samples was excited through a DAPI filter 
(405/20 nm). Excitation and emission light were separated through a 425 dclp 
beam splitter. GFP2 fluorescence was detected through a 500/20 nm filter; 
EYFP fluorescence through a 535/30 nm filter. As expression levels and 
fluorescence intensities were usually high, a 90% neutral grey filter was used 
to dim the excitation light. Camera sensitivity was increased by 4X4 binning. 
Exposure times were adjusted for each experiment, but were usually not 
higher than 200 ms. Five to six different stage positions were usually recorded 
in one experiment using a 63x oil objective. 
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b) Wide field microscopy for PKC probes using ECFP and FlAsH 
 
Fluorescence imaging of FlAsH labeled probes was performed on a Zeiss 
Axiovert 135 inverted microscope with a 63x oil immersion objective. Cells 
labeled as described in 3.2.1.8, were mounted in an appropriate holder and 
placed on the microscope at room temperature. Samples were excited at 
420/20 nm (dichroic 450 nm) with light from a polychrome IV (Till Photonics). 
Pictures were taken every 1.5 s with different illumination times (usually less 
than 50 ms). Fluorescence was measured in an area inside the cell to 
minimize artifacts caused by background. The emission ratio, FlAsH to ECFP, 
was measured with emission filters 475/40 nm (ECFP) and 535/25 nm 
(FlAsH), beam splitter dclp 505 nm. The emission ratio was corrected for 
bleed-through of ECFP into the FlAsH channel to give a corrected emission 
ratio (bleed-through of FlAsH into the ECFP channel is negligible). FlAsH 
emission at 490 nm was determined in order to subtract the direct excitation of 
FlAsH. 
 
3.2.1.10 Live cell imaging with confocal microscopy 
 
Confocal imaging was performed on a Leica SP2 AOBS system. 
Cell medium was replaced by HEPES buffer one hour before the experiments. 
Cells were kept at 37°C and 5% CO2. The experiments were performed at 
room temperature. Cell dishes were taken out of the incubator 10 min prior to 
the experiments, to equilibrate to room temperature. 
Compounds for addition were prepared as 1000x stock solutions in DMSO or 
water according to the protocol of the supplier. The compounds were pre-
dissolved in 50 µl buffer before addition to the experiment. 
GFP2 in all KCP-1 and KCP-2 samples was excited with a 405 nm laser. 
Emission for GFP2 was measured between 490 to 510 nm; for EYFP between 
520 to 540 nm. EYFP was directly excited using a 514 nm laser. 
The FRET pair mOrange/ mCherry was imaged using a 532 nm laser for 
excitation. Emission of mOrange was measured from 560 to 600 nm; mCherry 
from 610 to 650 nm. 
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Laser and PMT power were adjusted for each FRET experiment, but PMT 
values were set the same for both channels. 
Pictures were taken every 15 s with two line averages for each image. 
3.2.1.11 Data analysis 
 
If not otherwise mentioned, live cell FRET experiments were analyzed as 
follows: the fluorescence intensities of both channels (donor and acceptor) 
were directly taken from the unprocessed original microscope data set. 
Regions of interest (ROI) were defined in the cytosol of the cell and in the 
background not overgrown with cells. Mean fluorescence intensities were 
calculated using ImageJ268. The background was subtracted for each time 
point and the ratio of acceptor/ donor mean intensities in the chosen ROI were 
calculated. The result was normalized to the value one, using the scientific 
analysis program Origin269. 
Cells chosen for analysis usually expressed the probes to a medium level. 
The nucleus was excluded from data analysis, as it does not show a change 
in emission ratio, thereby lowering the cytosolic signal. The nucleus data were 
usually taken as a reference, but not shown in the figures for clarity.  
3.2.1.12 Acceptor photo-bleaching experiments 
 
FRET efficiencies were determined by acceptor photo-bleaching experiments 
(2.2.1). 
Experiments were performed on a Leica AOBS SP2 equipped with strong 
lasers for photo-bleaching and making use of the FRET acceptor photo-
bleaching module provided by the Leica software. 
First, pictures of the two fluorophores were taken at their excitation maximum. 
Subsequently, the acceptor was bleached at its excitation maximum. Finally, 
images of both fluorophores were taken again at their excitation maximum. A 
picture always consisted of an average of four scans. See Table 3.1 for laser 
settings. 
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 GFP2 EYFP mOrange mCherry 
Donor excitation 405 nm  532 nm  
Acceptor excitation  514 nm  594 nm 
Donor emission 490-510 nm  550-585 nm  
Acceptor emission  525-545 nm  610-645 
Bleach λ  514 nm  594 nm 
Table 3.1 Laser settings for acceptor photo bleaching experiments 
 
Data were analyzed using an ImageJ plugin originally written by Alen Piljić 
(EMBL, Heidelberg) and modified to suit these experiments. 
The plugin takes pre- and post-bleaching pictures of the donor, first subtracts 
the background and then runs a median filter with two iterations over it, to 
remove noise. The images are then thresholded and the pre-bleach picture is 
subtracted from the post-bleach picture. A median filter (single iteration) was 
applied to the resultant picture. Finally, the percent FRET efficiency was 
calculated by dividing the subtracted picture by the post-bleach picture. 
3.2.1.13 Cell lysates and trypsination experiments 
 
Trypsination experiments are another method to study FRET efficiencies. 
Trypsin proteolytically cleaves the probe, leaving the fluorophores intact, so 
that they diffuse and FRET cannot be observed any more. 
HeLa cells were transfected in round dishes (Ø 40 mm) with the constructs of 
interest. Cells were harvested 20-48 h after transfection, washed with PBS 
and detached with Trypsin. Trypsination was stopped by addition of 5 ml 
medium or Optimem. Cells were spun down in a centrifuge at 4°C and 300 g 
for 10 min. Cells were washed with PBS after the first centrifuge run and spun 
again. PBS was discarded and the cell pellet resuspended in RIPA buffer (100 
mM NaCl, 50 mM HEPES, 1% NP-40, pH 7.4). The mixture was left rocking in 
the cold room for 15 min and then centrifuged for 15 min at 4°C and 14000 
rpm (Eppendorf table centrifuge). Finally, the supernatant was transferred to a 
clean tube. The lysates were kept in the dark at 4°C. 
Emission ratios of the samples were measured on the same day in 10 µl 
cuvettes in the fluorimeter. EYFP/GFP2 FRET pairs were excited with 405 nm 
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and the emission measured between 485 and 545 nm (2 nm step size, 
integration time 1 s). The FRET pair mOrange/mCherry was excited at 532 
nm and the emission was measured from 550 to 650 nm (2 nm step size, 
integration time 1 s). In order to destroy the FRET between both fluorophores 
in a FRET pair, trypsin (4 µl of PBS with 0.5% trypsin) was added to the 
cuvette and the emission wasrecorded 5 min after addition. Finally, the 
percent FRET efficiency was calculated by dividing the difference in average 
fluorescence intensity between 490-510 nm (550-585 nm for mOrange) before 
and after trypsin by the average fluorescence intensity between 490-510 nm 
after trypsin cleavage(550-585 nm for mOrange). 
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3.2.2 Cloning of Constructs 
3.2.2.1 Introduction 
 
Plasmids of the so called dummy construct, KCP-11 and KCP-22, were 
obtained from Andreas Schleifenbaum (EMBL, Heidelberg). 
The dummy construct consists of a vector which encodes an N-terminal EYFP 
and a C-terminal GFP2, linked by a dummy sequence. The dummy sequence 
(717 bp) does not code for anything specific, it only serves as placeholder. 
Cutting with BbsI releases this dummy sequence and opens NcoI and BamHI 
sites into which any sequence can be inserted. The sequence will then be 
placed between the two fluorophores (see Fig. 3.2 A). 
The original KCP-1 probe has an insert of 239 amino acids instead of the 
dummy sequence. This insert is derived from pleckstrin and contains three 
phosphorylation sites that are recognized by PKC. The phosphorylation sites 
are flanked by a PH domain on the N-terminal side and a DEP domain on the 
C-terminal side (see Fig. 3.2 B). 
 
Fig. 3.2 Schematic representation of vectors and restriction sites used for cloning of 
constructs  
A Representation of the dummy construct, which contains both fluorophores, but no pleckstrin 
insert.  
B Representation of KCP-1, which contains both fluorophores and the long pleckstrin insert 
with the acidic loop (amino acids 1-239). 
C Representation of KCP-2, which contains both fluorophores and the short pleckstrin insert 
lacking the acidic loop (amino acids 1-221). 
For a detailed description of these constructs, see 3.2.2.1. 
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KCP-2 is a truncated version of KCP-1 (see Fig. 3.2 C), missing the last 18 C-
terminal amino acids of pleckstrin (between the DEP domain and the second 
fluorophore). Within these 18 amino acids are five acidic ones. We therefore 
named this stretch the "acidic loop". 
The respective pleckstrin sequences, yielding the KCP-1 and KCP-2 
constructs, were obtained by digestion of pET9d-Pleckstrin (1-221) or pET9d-
Pleckstrin (1-239) with BamHI and NcoI, and subsequent ligation into the 
digested dummy construct. 
Changes to the fluorophores of the construct were either performed on the 
dummy construct, with the respective sequences for KCP-1 or KCP-2 inserted 
afterwards, or on the probes themselves. 
KCP-1 and KCP-2 always refer to the original clones from Andreas 
Schleifenbaum. They are the references to which all other clones are 
compared. If KCP-1 or KCP-2 is part of a construct's name (as suffix or 
prefix), this shows from where the clone has been derived. It also indicates 
the existence (KCP-1) or absence (KCP-2) of the acidic loop. As this thesis 
studies the effect of fluorophores on probe performance, the fluorophores are 
changed quite often, while the pleckstrin derived sequence remains the same 
as in KCP-1 and KCP-2, respectively. 
3.2.2.2 Variations in the N-terminal linker region 
 
a)  Additional amino acids in the N-terminal linker region 
 
Additional amino acids were introduced into KCP-1 and KCP-2 using 
oligonucleotide ligation. For this, a unique BspEI restriction site in the N-
terminal linker region was used (see Fig. 3.3). DNA oligonucleotides coding 
for 3, 6, 10 or 12 amino acids and sticky ends complementing the BspEI site 
were designed. These DNA oligonucleotides were cloned into the vector 
plasmid according to the protocol for oligonucleotide ligation (3.2.1.3). 
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Fig. 3.3 Introduction of additional amino acids into KCP-1 and KCP-2 
Three, six, ten or twelve additional amino acids were introduced into a unique BspEI 
restriction site in KCP-1 and KCP-2.  
For a detailed description of cloning, see 3.2.2.2 a. 
 
Table 8.1 in the appendix shows an overview of primers and target vectors 
used for constructs with additional amino acids in the N-terminal linker of 
KCP-1 and KCP-2. 
 
b)  Deletion of amino acids in the N-terminal linker region 
 
Five non-structural C-terminal amino acids of YFP were deleted.  A BsrGI site, 
which usually is adjacent to the C-terminus of EYFP, was deleted at the same 
time (see Fig. 3.4). The deletions were introduced by PCR on the N-terminal 
EYFP. The PCR product was cloned into KCP-1 or KCP-2 using AgeI and 
BspEI. 
 
Fig. 3.4 Deletions of amino acids in the N-terminal linker region 
Amino acids were deleted at the C-terminus of EYFP and at the N-terminus of the PH domain 
in the original KCP-1 and KCP-2 constructs. 
For a detailed description of cloning, see 3.2.2.2 b. 
 
In a second set of experiments, the first seven amino acids of the PH domain 
were deleted in order to examine the effect of a reduction in linker length (see 
Fig. 3.4). These deletions were introduced by PCR on the pleckstrin insert of 
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KCP-1 or KCP-2. The PCR product was cloned into KCP-1 or KCP-2 using 
BspEI and BamHI. 
 
Table 8.2 in the appendix shows an overview of primers and target vectors 
used for constructs with deletions of amino acids in the N-terminal linker 
region of KCP-1 and KCP-2. 
 
c) Changes in the charge distribution of the PH domain 
 
The PH domain contains three basic residues within the first seven amino 
acids at the N-terminus: Lys4, Arg5 and Arg7. These amino acids were 
mutated to glutamic acid, to replace the positive charges with negative 
charges in the NegPH constructs. In the NeutPH constructs, amino acids 4 
and 5 were mutated to leucine and amino acid 7 to serine (see Fig. 3.5). 
These mutations were introduced by PCR on the pleckstrin insert of KCP-1 or 
KCP-2. The PCR product was cloned into KCP-1 or KCP-2 using BspEI and 
BamHI. 
 
Fig. 3.5 Changes in the charge distribution of the PH domain 
Three basic amino acids in the N-terminus of the PH domain were replaced either by acidic or 
neutral amino acids.  
For a detailed description, see 3.2.2.2 c.  
 
So called complementary clones were made, in which we mutated the acidic 
residues in the acidic loop to basic ones and the basic residues at the 
beginning of the PH domain to acidic ones. Justin Brumbaugh (EMBL, 
Heidelberg) made constructs, in which amino acids E227 and E228 were 
replaced by arginines and other constructs in which DDD232-234 were replaced 
by arginines. As described in the previous paragraph, the pleckstrin insert for 
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KCP-1, with either neutral or negative charges in the pH domain, was inserted 
into these clones, yielding the following constructs: NeutPHKCP-1_RR227/228, 
NeutPHKCP-1_RRR232-234, NegPHKCP-1_RR227/228 and NegPHKCP-
1_RRR232-234. 
 
Table 8.3 in the appendix shows an overview of primers and target vectors 
used for constructs containing changes in the charge distribution of amino 
acids in the N-terminal part of the PH domain of KCP-1 and KCP-2. 
3.2.2.3 Effect of fluorophore dimerization on KCP-1 and KCP-2 
 
The mutation A206K is known to render the normally dimeric fluorescent 
proteins, derived from Aequorea Victoria, as monomeric proteins270,271 (see 
structures in the Protein Data Bank under accession numbers 1GFL and 
1YFP). The mutation A206K was introduced into the two fluorophores EYFP 
and GFP2 of KCP-1 and KCP-2, to study the effect of protein oligomerization 
on the probe. The mutation was introduced individually into EYFP or GFP2 
with two sets of primers as described in 3.2.1.2 b. GFP2 was first replaced 
with mGFP2 (GFP2 A206K) in the dummy construct using BamHI and XbaI. 
The reverse primer for GFP2 (R1) also introduced a single A→C mutation, 
deleting the BsrGI site at the end of GFP2. In this way, BsrGI could be used as 
a restriction site in the following step. EYFP was replaced with mYFP (EYFP 
A206K) in the new EYFP-dummy-mGFP2 construct using NheI and BsrGI. 
The dummy site was subsequently replaced with either the KCP-1 or KCP-2 
sequence. 
Constructs containing only one monomeric fluorophore, mGFP2 or mYFP, 
were made by introducing the KCP-1 or KCP-2 sequence into a EYFP-
dummy-mGFP2 or a mYFP-dummy-GFP2 construct. 
The mutation L221K in fluorescent proteins derived from Aequorea victoria 
also decreases their ability to dimerize, but to a lesser degree than A206K. 
While the Kd for A206K variants is about 74 mM (although difficult to 
determine due to its strong monomeric behavior) the L221K variants still have 
a Kd of 9.7 mM270. This mutation was introduced in the same way as A206K 
(see 3.2.1.2 b). Different primers were, however, used for S2 and R2. 
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Fig. 3.6 Cloning of monomeric fluorophores in KCP-1 and KCP-2 probes 
Mutations (A206K and L221K), destroying the dimeric nature of the fluorescent proteins, were 
introduced into EYFP and GFP2.  
A Representation of the dummy construct with monomeric fluorescent proteins and the 
restriction sites used for cloning.  
B Representation of the probe with monomeric fluorescent proteins and the restriction sites 
used for cloning.  
For a detailed description of cloning procedures, see 3.2.2.3. 
 
Table 8.4 in the appendix shows an overview of primers and target vectors 
used for constructs with monomeric fluorophores in KCP-1 and KCP-2. 
3.2.2.4 Intra- versus intermolecular FRET in PKC probes 
 
As fluorophores tend to dimerize, they might show FRET not only within the 
same molecule but also between different molecules. If that is the case, one 
should be able to observe FRET by co-transfecting two constructs which are 
only able to FRET between molecules and not within the same molecule. 
We designed two sets of experiments to address this question: firstly, either 
one of the fluorophores was rendered non-fluorescent by introducing a Y66S 
point mutation into the fluorophore region. The mutation was introduced by 
site directed mutagenesis (see 3.2.1.2 a) on either KCP-1 or KCP-2, to give 
Y66SYFP-KCP-1/2-GFP2 (EYFP non-fluorescent and GFP2 fluorescent) and 
EYFP-KCP-1/2-Y66SGFP2 (EYFP fluorescent and GFP2 non-fluorescent). For 
a schematic illustration of constructs, please see Fig. 3.7 A and B. 
 
For the second experiment, constructs were made, which encode only one 
kind of fluorophore: EYFP-KCP1/2-EYFP and GFP2-KCP1/2-GFP2. 
For EYFP-KCP1/2-EYFP constructs, PCR was performed on EYFP 
introducing an N-terminal BamHI site and a C-terminal XbaI site. The PCR 
product was sub-cloned into the dummy construct to replace GFP2, resulting 
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in an EYFP-dummy-EYFP construct. The dummy site was subsequently 
replaced with either the KCP-1 or KCP-2 sequence. 
Fig. 3.7 Cloning of probes to discriminate between intra- and intermolecular FRET 
To discriminate between intra- and intermolecular FRET, two sets of experiments were 
designed, with FRET only possible between two molecules, not within one molecule.  Probes 
A and B were used in one experimental set up, probes C and D in another.  
A: Probe encoding a non-fluorescent EYFP and a fluorescent GFP2. 
B: Probe encoding a non-fluorescent GFP2 and a fluorescent EYFP.  
C: Probe encoding two yellow fluorescent proteins (EYFP).  
D: Probe encoding two green fluorescent proteins (GFP2). 
 
For GFP2-KCP1/2-GFP2 constructs, PCR was performed on GFP2 to 
introduce an N-terminal NheI site and a C-terminal BsrGI site. The PCR 
product was sub-cloned into the dummy construct used in 3.2.2.3 (BsrGI site 
removed from the C-terminus of GFP2) to replace with EYFP, resulting in a 
GFP2-dummy-GFP2 construct. The dummy site was subsequently replaced 
with either the KCP-1 or KCP-2 sequence. For a schematic illustration of 
constructs please see Fig. 3.7 C and D. 
 
Table 8.5 in the appendix shows an overview of primers and target vectors 
used for constructs distinguishing between intra- and intermolecular FRET. 
 
3.2.2.5 Changing the FRET pair in PKC probes 
 
a) PKC probes using AGT and chemically synthesized fluorophores 
 
Plasmids of constructs containing ECFP-dummy-EYFP and Citrine-dummy-
Citrine were obtained from Andreas Schleifenbaum. PCR was performed on 
the original AGT clones from Antje Keppler and these were introduced into the 
ECFP construct using BamHI and XbaI restriction sites. The resulting ECFP-
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dummy-AGT was opened with BbsI and the respective KCP-1 or KCP-2 
sequence was introduced (see Fig. 3.8 A). 
A shorter version of AGT, AGT177 was introduced into EYFP-dummy-GFP2 
by PCR on AGT177. The restriction sites used were NheI and BspEI. As AGT 
contains an internal BspEI site, a silent G→C mutation was introduced in the 
cloning process. The resulting AGT177-dummy-GFP2 was opened with BbsI 
and the respective KCP-1 or KCP-2 sequence was introduced (see Fig. 3.8 
B). 
Fig. 3.8 Construction of AGT fusion proteins to be labeled with chemically synthesized 
fluorophores 
Several different constructs were made, combining different genetically encoded fluorescent 
proteins with AGT. 
A AGT was cloned into a construct coding for ECFP as N-terminal fluorophore in KCP-1 and 
KCP-2 probes. 
B A shortened version of AGT, AGT177, was cloned into a construct coding for GFP2 as C-
terminal fluorophore in KCP-1 and KCP-2 probes. 
C AGT was cloned into a construct coding for Citrine as C-terminal fluorophore in KCP-1 and 
KCP-2 probes. 
D AGT was cloned into a construct coding for Citrine as N-terminal fluorophore in KCP-1 and 
KCP-2 probes. 
 
AGT was cloned into the Cit-dummy-Cit construct as replacement for the N-
terminal fluorophore using NheI and BspEI. The procedure was similar to the 
AGT177-dummy-GFP2 clone, however in this case the template was the full 
length AGT. The resulting AGT-dummy-Cit was opened with BbsI and the 
respective KCP-1 or KCP-2 sequence introduced (see Fig. 3.8 C). AGT was 
also cloned into the double Cit construct as a C-terminal fluorophore using 
BamHI and XbaI. The resulting Cit-dummy-AGT was opened with BbsI and 
the respective KCP-1 or KCP-2 sequence was introduced (see Fig. 3.8 D). 
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Table 8.6 in the appendix shows an overview of primers and target vectors 
used for constructs with AGT and genetically encoded fluorophore in KCP-1 
and KCP-2.  
 
b) PKC probes using FlAsH and ECFP 
 
The tetracysteine motif was introduced into ECFP-KCP-1-AGT and ECFP-
KCP-2-AGT (see 2.2.2.3 a) using BamHI and AvaI restriction sites. DNA 
oligos containing the tetracysteine motif FLNCCPGCCMEP and a stop codon 
were purchased and ligated into the target vector according to protocol 3.2.1.3 
to give ECFP-KCP-1-FlAsH and ECFP-KCP-2-FlAsH (see Fig. 3.9 A). 
In addition, constructs with a monomeric ECFP and FlAsH were made. The 
A206K mutation was introduced into ECFP using standard protocol (see 
3.2.1.2) and cloned into ECFP-KCP-1-FlAsH or ECFP-KCP-2-FlAsH using 
NheI and BsrGI (see Fig. 3.9 B) to give mCFP-KCP-1-FlAsH and mCFP-KCP-
2-FlAsH. 
Fig. 3.9 Constructs containing the tetracysteine motif 
The C-terminal fluorophore in KCP-1 and KCP-2 was replaced with a 12-amino acid 
tetracysteine motif for FlAsH labeling.  
A Constructs containing ECFP and the tetracysteine motif for FlAsH labeling.   
B Constructs containing mCFP and the tetracysteine motif for FlAsH labeling.   
 
Table 8.7 in the appendix shows an overview of primers and template vectors 
used for constructs encoding the FlAsH labelling sequence in KCP-1 and 
KCP-2 probes. 
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4 Results 
4.1 Introduction 
 
This thesis has three aims: Firstly, to study different factors that influence 
protein kinase C probe performance. Secondly, to increase the range of 
fluorophores used for FRET in order to make the probe more versatile for 
different applications such as multiparameter imaging. Third, to thoroughly 
understand the mechanism of action of our probes, we would like to create a 
probe that is significantly smaller than KCP-2 and can be studied with NMR. 
 
Fig. 4.1 Schematic representation of previously published PKC probes 
A Illustration of the set up of our previously published protein kinase C probes. The scheme 
denotes the different parts of the probe as used in this thesis. The probe consists of a 
pleckstrin insert sandwiched by two fluorophores (EYFP and GFP2). KCP-1 and KCP-2 differ 
only in the length of the pleckstrin insert, which is 239 aa long in KCP-1 and 221 aa long in 
KCP-2. 
B Hypothetic model of conformational change in the KCP-2 probe as suggested by NMR 
experiments performed with the pleckstrin insert alone: phosphorylation lead to stretching of 
the probe, which, in the model, would lower the FRET efficiency between both fluorophores. 
Please note, that the depicted model is not actual NMR data, but a model put together from 
structural data of the individual components. 
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Two previously published FRET-based probes for PKC activity, KCP-11 and 
KCP-22 designed in our lab, are used as references for all newly described 
probes. 
Both are stoichiometric probes containing an N-terminal EYFP and a C-
terminal GFP2. Between these two fluorophores is a sequence derived from 
pleckstrin, the major substrate of PKC in platelets272. It contains a 
phosphorylation loop of 14 amino acids recognized by PKC, which is flanked 
by a PH domain on the N-terminal side and a DEP domain on the C-terminal 
side. In the original KCP-1, this sequence is 239 amino acids long. KCP-2 is a 
truncated version of KCP-1, missing the last 18 C-terminal amino acids of 
pleckstrin (between the DEP domain and the second fluorophore). These 18 
amino acids in KCP-1 contain five acidic residues and are therefore named 
the "acidic loop" (see Fig. 4.1 for a schematic representation of the probes). 
Amino acids Ser 113, Thr 114 and Ser 117 of the pleckstrin insert in KCP-1 
and KCP-2 are phosphorylated by PKC. This phosphorylation induces a 
conformational change that leads to increased FRET in KCP-1 and decreased 
FRET in KCP-2. The emission ratio goes back to starting level if 
phosphorylation is inhibited, reflecting the activity of phosphatases removing 
the phosphates from the probe (Fig. 4.2 B). 
NMR experiments with the pleckstrin insert of KCP-1 (PH-P-DEP, but lacking 
both fluorophores) showed a closed conformation which stretched upon 
phosphorylation (Fig. 4.1 B). This fits well with the result seen in KCP-2: a 
stretched conformation might lead to an increased distance between the 
fluorophores and therefore reduces FRET efficiency. KCP-1 seems to 
undergo a different transformation, possibly due to additional interactions. 
This question will be addressed in detail in this thesis. 
 
EYFP and GFP2 are an efficient FRET pair206 as donor emission and acceptor 
excitation overlap broadly and the direct excitation of EYFP is below detection 
levels at the donor excitation maximum (see Fig. 4.2 A). 
KCP-1 shows a positive change in EYFP/GFP2 emission ratio upon PKC 
stimulation and a drop in emission ratio after inhibition (see Fig. 4.2 B). KCP-2 
shows the opposite signal, the EYFP/GFP2 emission ratio drops upon 
activation of PKC and increases again after inhibition (see Fig. 4.2 B). 
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Fig. 4.2 Basic set up of experiments performed to study probe performance 
A Normalized spectra of the excitation (dashed line) and the emission (solid line) of GFP2 
(green) and EYFP (orange).  
B In-vivo experiments with KCP-1 (black, green and cyan) and KCP-2 (red, blue and pink) 
performed in HeLa (green and blue) or N1E (black, red, cyan and pink) cell lines on two 
microscopes, Leica SP2 (black, red, green and blue) and Visitron (cyan and pink). The 
EYFP/GFP2 emission ratio is plotted over time. PKC activity was first stimulated with PMA 
then inhibited with Gö6983 after 10 min. Phosphorylation by PKC induced an increase in 
emission ratio in KCP-1, while it induced a decrease in KCP-2. The inhibition of PKC caused 
a reversal of the signal back to basal levels in both probes.   
C Chemical structure of the PKC activator PMA (phorbol-12-myristate-13-acetate). 
D Chemical structure of the PKC inhibitor Gö6983 (2-[1-(3-Dimethylaminopropyl)-5-
methoxyindol-3-yl]-3-(1H-indol-3-yl) maleimide). 
 
In order to make probe performance comparable, all experiments have the 
same basic set up - the PKC probe to be studied is transfected into 
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mammalian cell lines and imaged on a fluorescence microscope after protein 
expression. Protein kinase C activity is first stimulated by addition of PMA 
and, after 10 min, inhibited by Gö6983. The data is analyzed by determination 
of the ratio of acceptor to donor emission. 
PKC stimulation is achieved by addition of PMA (phorbol-12-myistate-13-
acetate, see Fig. 4.2 C). This phorbol ester activates PKC specifically and has 
a long-lasting effect68,273. PKC can also be activated with more physiological 
stimuli, such as histamine274,275 or bradykinin276,277. Addition of these 
substances leads to phosphorylation of the probe. Their effect is usually short 
lived and sometimes not as strong as that of phorbol esters. Since the 
properties of KCP-1 and KCP-2 as a protein kinase C probe have been 
established and published, there was no need to show their ability to respond 
to physiological activators. Instead, we wanted to see a reliable, large and 
sustained response every time, in order to compare probe performance. This 
is best achieved by stimulating with PMA. 
Inhibition of PKC activity is achieved by addition of Gö6983 (see Fig. 4.2 D), 
which is a potent and cell permeable inhibitor for most PKCs278. 
 
Two microscopes have mainly been used for this study: a confocal laser 
scanning microscope (Leica SP2) and a multi-stage wide field system 
(Visitron). Both show the same kind of signal in both probes, but the amplitude 
of the signal is different. While the signal in KCP-1 probes increased to 21.5% 
on the Leica SP2, it only increased to 10.6% on the Visitron system (see Fig. 
4.2 B, black, red, green and blue lines). Likewise for KCP-2, the signal on the 
Leica SP2 decreased by 19-23%, while it only decreased by 15% on the 
Visitron (see Fig. 4.2 B, cyan and pink lines). This is due to different filter 
properties in the microscope set up. The SP2 has an AOBS system, which 
allows the user to define the range of measured emission in nanometer steps 
thereby allowing a better separation of the two emissions from each other. 
The Visitron system has preset filters that are more broadly defined and 
therefore have a much higher bleed through of one detection channel into the 
other. To compare different constructs to each other, they have to be 
performed on the same microscope. All results presented here contain the 
traces of the original probes, KCP-1 and KCP-2, imaged under the same 
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conditions for comparison. Most experiments have been performed on the 
Visitron system as it allows fast imaging of several samples in parallel. The 
Leica SP2 was used to image pairs of fluorophores other than EYFP/GFP2, or 
when expression levels had to be determined, as this microscope allows for 
accurate setting of emissions. An additional advantage of imaging on the 
Visitron system is that the signal to noise ratio is better than on the Leica SP2. 
This is especially important when measuring probes that display only small 
changes in emission ratio. 
Traces of changes in emission ratio for each probe are shown as an average 
of at least ten cells measured in at least three independent experiments. 
 
The original KCP-1 and KCP-2 probes perform well in different cell lines. Fig. 
4.2 B shows that the cell line chosen did not influence the signal amplitude or 
shape. KCP-1 showed an increase in emission ratio of approximately 20% 
upon PKC activation on the Leica SP2 microscope, independent of the cell 
type (N1E= black line; HeLa= green line). The same is true for KCP-2, which 
showed a decrease in emission ratio of 20% upon PKC activation on the Leica 
SP2 microscope for both cell lines (N1E= red line; HeLa= blue line). N1E cells 
were preferred to HeLa cells as they have a round morphology and therefore 
small focus drifts during a longer time course only had a small effect. 
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4.2 Variations in the N-terminal linker region 
4.2.1  Additional amino acids in the N-terminal linker region 
 
As FRET efficiency strongly depends on the distance between the 
fluorophores, we first studied the effect of an increased linker length in the N-
terminal linker region (Fig. 4.1 A). In the original KCP-1 and KCP-2 probes this 
linker has a length of six amino acids (Leu-Tyr-Lys-Ser-Gly-Ala). It contains 
three restrictions sites for cloning. One of these sites, BspEI, was used to 
introduce additional amino acids and elongate the linker region (see 3.2.2.2 
A). If more than six amino acids were added, the sequence was designed to 
code for short α-helical stretches. 
Clone  Inserted DNA sequence Additional aa inserted 
between Ser and Gly 
3SKCP TCC GGT GCG GCC GGA Ser-Gly-Ala-Ala-Gly 
3RKCP TCC GGC CGC ACC GGA Ser-Gly-Arg-Thr-Gly 
6SKCP TCC GGC GCC AAC ATC GTG 
TCC GGA 
Ser-Gly-Ala-Asn-Ile-Val-
Ser-Gly 
6RKCP TCC GGA CAC GAT GTT GGC 
GCC GGA 
Ser-Gly-His-Asp-Val-Gly-
Ala-Gly 
10SKCP TCC GGC ATG TTC TCT ATC 
AAC CGC GTG TAC GCC GGA 
Ser-Gly-Met-Phe-Ser-Ile-
Asn-Arg-Val-Tyr-Ala-Gly 
10RKCP TCC GGC GTA CAC GCG GTT 
GAT AGA GAA CAT GCC GGA 
Ser-Gly-Val-His-Ala-Val-
Asp-Arg-Glu-His-Ala-Gly 
6R6SKCP TCC GGA CAC GAT GTT GGC 
GCC GGC GCC AAC ATC GTG 
TCC GGA 
Ser-Gly-His-Asp-Val-Gly-
Ala-Gly-Ala-Asn-Ile-Val-Ala-
Gly 
Table 4.1 DNA and amino acid sequences introduced into KCP-1 or KCP-2 
Nucleotides inserted into the BspEI restriction site of KCP-1 or KCP-2 site are shown in red, 
the BspEI restriction site (TCCGGA) is shown in black. Additional amino acids in the protein 
are shown in blue, flanked by the original ones in black. 
 
As only one restriction site was used, the oligonucleotides were able to anneal 
in two different orientations: the sense orientation, which yielded amino acids 
with the desired secondary structure (called "S" constructs, see Table 4.1); 
and the reverse orientation, introducing a different sequence of the same 
length with random structure (named "R" constructs, see Table 4.1). The 
constructs were named with numbers, according to the number of additional 
amino acids, and an "S" or "R" according to the orientation in which the 
oligonucleotide was introduced into the restriction site. KCP-1 or KCP-2 
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indicated into which probe the amino acids were inserted. For example, the 
construct 6SKCP-1 has six additional amino acids, introduced in sense 
orientation into the original KCP-1 construct. 
Fig. 4.3 Introduction of additional amino acids in the N-terminal linker region of KCP-1 
Additional amino acids were introduced in the N-terminal linker region of KCP-1. Experiments 
were performed on the Visitron system on slides spotted with DNA and covered with HeLa 
cells.  
A PKC activity was stimulated by addition of 200 nM PMA after 6 min and the EYFP/GFP2 
emission ratio measured over time. PKC activity was inhibited 10 min after activation by 
addition of 500 nM Gö6983, but data is not shown for clarity. The emission ratio of the original 
probe KCP-1 (black line) increased substantially upon PKC activation. With increasing length 
of the N-terminal linker, the amplitude of the signal became gradually smaller. 
B Single cell examples from the experiments are color-coded according to FRET level. A 
change in emission ratio, i.e. FRET level, is seen as a change in color. Introduction of more 
than three amino acids led to reduced or abolished signal in KCP-1 probes. 
 
The constructs were spotted on welled cover slips and imaged simultaneously 
on the Visitron system (3.2.1.6). One image per spot per minute was taken 
and a maximum of 27 spots (nine constructs in triplicate), imaged in parallel. 
The original KCP-1 or KCP-2 probes were spotted on every cover slip as a 
reference and a control. 
 
A strong effect of linker length on probe performance could be observed in 
KCP-1 derived probes: the longer the linker, the weaker the change in 
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emission ratio upon PKC stimulation (see Fig. 4.3). The original KCP-1 probe 
showed an increase in EYFP/GFP2 emission ratio of 14% (Fig. 4.3 A, black 
line) upon activation of PKC with PMA. If three amino acids were added in the 
N-terminal linker region, the same increase of 14% was detected (Fig. 4.3 A, 
red and green lines). If six amino acids were added, the increase in emission 
ratio was only 5.5-7% (Fig. 4.3 A, dark and light blue lines), half the increase 
shown by the original probe. If ten or twelve amino acids were added the 
signal was abolished (Fig. 4.3 A, yellow, pink and khaki lines). This effect is 
independent of the orientation in which the oligonucleotides were inserted. 
Fig. 4.4 Introduction of additional amino acids in the N-terminal linker region of KCP-2 
Additional amino acids were introduced in the N-terminal linker region of KCP-2. Experiments 
were performed on the Visitron system on slides spotted with DNA and covered with HeLa 
cells.  
A PKC activity was stimulated by addition of 200 nM PMA after 6 min and the EYFP/GFP2 
emission ratio measured over time. PKC activity was inhibited 10 min after activation by 
addition of 500 nM Gö6983, but data is not shown for clarity. The emission ratio of the original 
probe KCP-2 (black line) decreased substantially upon PKC activation. Increasing the length 
of the N-terminal linker slightly diminished the amplitude of the signal.  
B Single cell examples from the experiments are color-coded according to height of FRET 
level. A change in emission ratio, i.e. FRET level, is seen as change in color. Introduction of 
amino acids led to a slightly reduced signal in KCP-2 probes. 
 
The effects of increased linker length on probe performance in KCP-2 
samples were similar to KCP-1 (Fig. 4.5). The original KCP-2 probe showed a 
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decrease in EYFP/GFP2 emission ratio of 16% upon PKC activation (Fig. 4.4 
A, black line). The change in emission ratio was also 16% if three amino acids 
were added to the N-terminal linker region. With six additional amino acids, 
the emission ratio decreased by 12-13%, and with ten additional amino acids, 
the signal decreased by 10-11%. The longer the introduced linker, the smaller 
the change in emission ratio for the KCP-2 probes. These results for KCP-2 
showed the same trend as in KCP-1, although significantly less pronounced 
(Fig. 4.5). 
 
Fig. 4.5 Change in emission ratio after phosphorylation in KCP-1 and KCP-2 probes 
The change in EYFP/GFP2 emission ratio (in %) is shown depending on the amount of amino 
acids introduced in the N-terminal linker region of PKC probes. Addition of amino acids leads 
to reduced probe performance in both probes, although the effect is much stronger in KCP-1 
(black line) than KCP-2 (red line). 
 
The cell pictures in Fig. 4.3 B and Fig. 4.4 B were color-coded according to 
FRET level. Blue stands for low FRET levels, red for high FRET levels. 
Original cell pictures were taken from both channels and the ratio calculated 
using ImageJ. A strong color change indicates a strong change in emission 
ratio. This color coding is used throughout this thesis to demonstrate changes 
in FRET levels directly on the cells. As can be seen in both figures, Fig. 4.3 B 
and Fig. 4.4 B, the change in emission ratio of the probes only took place in 
the cytosol, not in the nucleus. The nucleus remained white or blue in the 
color-coded KCP-1 pictures (first and second panel, Fig. 4.3 B), while the 
cytosol turned red after PKC activation, indicating a decrease in EYFP/GFP2 
emission ratio. The same was found for all KCP-2 samples: the nuclei 
remained red or white, while the cytosol turned blue, indicating a decrease in 
EYFP/GFP2 emission ratio. This was expected as PKC is not active in the 
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nucleus. Observation of the signal in the nucleus was a good control showing 
that the probes indeed measured activation or inhibition of PKC and not an 
artifact. If the measurements had resulted from an artifact, we would expect 
the signal to be in the whole cell, not only in certain compartments. 
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4.2.2 Deletion of amino acids in the N-terminal linker region 
 
As we could show that an increase in linker length had a significant effect on 
the performance of KCP-1 derived probes, we were interested in studying the 
effect of a decreased linker length in these probes. 
According to the crystal structure of GFP and its variants (PDB ID: 1GFL, 
1YFP), the C-terminal end (aa 231-236) of the fluorescent protein is flexible 
and not involved in the overall fluorophore structure196,279. 
Fig. 4.6 Deletion of amino acids in the N-terminal linker region of KCP-1 
Amino acids were deleted in the N-terminal linker region of KCP-1. Experiments were 
performed with HeLa cells on the Visitron system.  
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. The original KCP-1 probe (black line) showed an increase in emission ratio upon PKC 
activation. YFP∆8KCP-1 (red line) showed a similar response, though the signal was smaller 
than the original one. In PH∆7KCP-1 (green line) the signal was reversed: phosphorylation 
resulted in a decrease in emission ratio.  
B Single cell examples from the experiments are color-coded according to FRET level. A 
color change, indicating a change in emission ratio of the probes, could be seen in all panels, 
although the direction of the signal was reversed in PH∆7KCP-1. 
 
We deleted these five C-terminal amino acids, as well as a BsrGI restriction 
site, which is usually adjacent to the C-terminus of EYFP. In total, eight amino 
acids were deleted from the linker region between the N-terminal EYFP and 
   
Results   71 
the PH domain of pleckstrin in the KCP-1 and KCP-2 probes (3.2.2.2). These 
constructs were named YFP∆8KCP-1 and YFP∆8KCP-2. 
In addition, we deleted the first seven amino acids of the PH domain, at the 
beginning of the pleckstrin insert and an alanine ahead of the start-
methionine. These constructs were called PH∆7KCP-1 and PH∆7KCP-2. 
Deletion of eight amino acids in YFP∆8KCP-1 resulted in a decrease in signal 
amplitude of about 35%. While the emission ratio upon phosphorylation 
increased to about 9.6% in the original KCP-1 probe, it only increased to 6.3% 
in the shortened probe (Fig. 4.6 A). The emission ratio was lowered after 
addition of Gö6983, reflecting the activity of phosphatases dephosphorylating 
the probe. 
Fig. 4.7 Deletion of amino acids in the N-terminal linker region of KCP-2 
Amino acids were deleted in the N-terminal linker region of KCP-2. Experiments were 
performed with HeLa cells on the Visitron system.  
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. The original KCP-2 probe (black line) showed a decrease in emission ratio upon PKC 
activation. In both shorter samples (YFP∆8KCP-2, red line and PH∆7KCP-2, green line) the 
amplitude of the signal was smaller than in the original KCP-2 probe. 
B Single cell examples from the experiments are color-coded according to FRET level. A 
color change, indicating a change in emission ratio of the probes, could be seen in all panels, 
although it was much smaller in the shorter probes.   
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Deletions of amino acids in the PH domain (PH∆7KCP-1), however, led to a 
reversal of the signal: upon PKC activation the EYFP/GFP2 emission ratio 
decreased to -5%. Addition of Gö6983 reversed the signal and brought it back 
to basal level. 
A significant effect could also be observed when deleting the same amino 
acids in the KCP-2 probes. While the original KCP-2 showed a decrease in 
emission ratio of 15% after PKC activation, the signal was weaker in the 
shortened probes, only 8% in YFP∆8KCP-2 and PH∆7KCP-2. Although there 
was a clear signal, it was only 55% of the original amplitude of KCP-2. 
Deletion of amino acids in the N-terminal linker had strong effects on both 
probes. If the C-terminus of EYFP was shortened, both probes showed 
significantly reduced probe performance. If the N-terminus of the PH domain 
was deleted, the effect in PH∆7KCP-1 was even stronger than in YFP∆8KCP-
1 as the signal was reversed in direction. As we will see in the next 
paragraphs, this is not due to linker shortage, but mainly due to changes in 
the PH domain. 
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4.2.3 Changes in the charge distribution of the PH domain 
 
As mentioned before, the only difference between KCP-1 and KCP-2 is a 
stretch of 18 amino acids at the C-terminus of the pleckstrin insert. This so-
called acidic loop contains two glutamates (residues 227 and 228 of the 
pleckstrin insert) and three aspartates (residues 232-234 of the pleckstrin 
insert). The different responses of the two KCP probes might be due to 
interactions of these amino acids with other residues in the molecule (Fig. 
4.8).   
 
Fig. 4.8 Working model for KCP-1 
A model for the conformational change in the KCP-1: in an unphosphorylated state the 
negatively charged residues in the acidic loop do not interact. The longer linker separates 
both fluorophores further in KCP-1 than in KCP-2. Phosphorylation leads to a conformational 
change that induces closer interaction of the negatively charged residues in the acidic loop 
with positively charged amino acids in the PH domain. Please note the depicted model is not 
actual structural data, but a model put together from structural data of the individual 
components. 
 
The PH domain at the beginning of the pleckstrin insert contains three basic 
residues within the first seven amino acids: Lys4, Arg5 and Arg7. These 
amino acids might be interaction partners for polar interactions with the acidic 
loop. To test this hypothesis, we mutated these three amino acids in the PH 
domain to either neutral (NeutKCP-1 or NeutKCP-2) or negative (NegKCP-1 
or NegKCP-2) residues. 
 
Replacing these basic amino acids with neutral ones (K4L, R5L and R7S) in 
KCP-1 led to a reduced signal. Instead of an increase of 9.6% as in the 
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original KCP-1 probe, we saw an increase of only 6% in the emission ratio 
after PKC stimulation. 
Fig. 4.9 Changes in the charge distribution of the pH domain of KCP-1 
The basic charges at the start of the PH domain in KCP-1 were exchanged with neutral 
(NeutKCP-1) or acidic (NegKCP-1) ones. Experiments were performed in N1E cells on the 
Visitron system.  
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. The original KCP-1 probe (black line) showed an increase in emission ratio upon PKC 
activation. NeutKCP-1 (red line) still had a positive response to PKC stimulation, but with 
smaller amplitude. The signal was reversed in NegKCP-1 (green line). 
B Single cell examples from the experiments are color-coded according to FRET level. A 
distinctive color change, indicating a significant change in emission ratio of the probe, was 
seen in the first panel (showing the original KCP-1 probe). NeutKCP-1 showed an increase of 
FRET after phosphorylation, but with smaller amplitude. NegKCP-1 displayed the opposite 
behavior, the emission ratio dropped after PKC stimulation. 
 
Replacing the amino acids with negatively charged ones (K4E, R5E and R7E) 
had a stronger effect on the probe: the signal was reversed. After 
phosphorylation by PKC the EYFP/GFP2 emission ratio of NegKCP-1 dropped 
by 10% instead of increasing as in KCP-1. While addition of Gö6983 usually 
brought the emission ratio of probes back to starting level, it only went back to 
about -5% in the NegKCP-1 probe. The kinetics of the probe also seemed to 
be altered. The change in emission ratio after phosphorylation was usually 
quite fast. This fast response was also observed in most modified probes, not 
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only in KCP-1 and KCP-2. In the NegKCP-1 probe, however, the drop in 
emission ratio was much slower than in other probes. 
Similar replacements in KCP-2 led to reduced probe performance. The 
direction of the signal, though, remained the same. 
While the EYFP/GFP2 emission ratio of the original KCP-2 probe decreased 
by 15% upon phosphorylation, it only decreased by 9% in the NeutKCP-2 
probe and by 12% in the NegKCP-2 probe (Fig. 4.10 B, red and green line). 
This corresponds to 80% of the original signal in NegKCP-2 and 60% in 
NeutKCP-2. 
Fig. 4.10 Changes in the charge distribution of the pH domain of KCP-2 
The basic charges at the beginning of the PH domain in KCP-2 were exchanged for neutral 
(NeutKCP-2) or acidic (NegKCP-2) ones. Experiments were performed in N1E cells on the 
Visitron system.  
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. The original KCP-2 probe (black line) showed a decrease in emission ratio upon PKC 
activation. NeutKCP-2 (red line) and NegKCP-1 (green line) also displayed a negative 
response to PKC stimulation, but with smaller amplitude. 
B Single cell examples from the experiments are color-coded according to FRET level. A 
distinctive color change, indicating a significant change in emission ratio of the probe, is seen 
in the first panel showing the original KCP-2 probe. NeutKCP-2 and NegKCP-2 showed some 
change in FRET levels, but not as pronounced as for the original KCP-2 probe. 
 
The results observed, when the basic amino acids were replaced with neutral 
or negatively charged residues, are similar to the experiments discussed in 
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the previous chapter, where amino acids of the PH domain were deleted from 
the sequence. 
 
Based on the model in Fig. 4.8, there is another explanation for the 
conformational change in KCP-1, which takes the reversal of the signal in the 
NegKCP-1 probe into account. If the acidic loop is interacting with the amino 
acids in the PH domain, destroying this interaction might lead to a reversal of 
signal: the additional interaction is missing, therefore the probe is stretching. 
This leads to a greater distance between the two fluorophores resulting in a 
decrease in FRET (according to the model for KCP-2 in Fig. 4.1 B). 
If there is an interaction between the acidic loop and the residues 4, 5 and 7 of 
the PH domain that was determined by the charge of those amino acids, the 
interaction might be restored by creating complementary probes, in which we 
introduce basic amino acids into the acidic loop and acidic amino acids into 
beginning of the PH domain. 
Justin Brumbaugh (Schultz group, EMBL) made constructs in which he 
replaced the amino acids Glu227 and Glu228 in the acidic loop with arginines. 
He also replaced three glutamates, amino acids 232-234, with arginines in a 
second construct. The previously shown constructs, encoding for either 
neutral or negative charges in aa 4, 5 and 7 of the PH domain, were 
introduced into these vectors, creating four different clones having either a PH 
domain with neutral amino acids and positive charges in the acidic loop, or a 
PH domain with negative charges and positive charges in the acidic loop: 
NeutKCP-1RR227/228, NeutKCP-1RRR232-234, NegKCP-1RR227/228 and 
NegKCP-1RRR232-234. 
Both constructs with neutral amino acids in the PH domain, showed a small 
positive response upon phosphorylation (Fig. 4.11 A). If DDD232-234 were 
replaced by arginines, the increase was 5.6%, whereas if EE227/228 were 
replaced by arginines the increase was only 2.6%. This relates to 58% of the 
signal of the original probe in the NeutKCP-1RRR232-234 construct and to 27% 
in the NeutKCP-1RR227/228 construct. This was similar to the results for the 
constructs with neutral amino acids in the PH domain, but unchanged acidic 
loop (Fig. 4.9 A). 
 
   
Results   77 
Fig. 4.11 Complementing charge changes in KCP-1 
The basic charges at the start of the PH domain in KCP-1 were exchanged for neutral or 
acidic ones. At the same time negative charges in the acidic loop were replaced by positive 
ones. Experiments were performed in N1E cells on the Visitron system. 
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. The original KCP-1 probe (black line) showed an increase in emission ratio upon PKC 
activation. The neutral constructs showed a positive change in emission ratio, but with smaller 
amplitude. The negative constructs displayed a decrease in emission ratio. 
B Single cell examples from the experiments were color-coded according to FRET level. A 
distinctive color change, indicating a significant change in emission ratio of the probe, was 
seen in the first panel showing the original KCP-1 probe.  
 
If the construct had a PH domain with negatively charged amino acids and 
positive charges in the acidic loop, the direction of the signal was reversed 
(Fig. 4.11 A), similar to the result seen for the NegKCP-1 construct (Fig. 4.9 
A). While the signal in NegKCP-1RRR232-234 decreased by 2.7%, the signal in 
the NegKCP-1RR227/228 probe decreased by 7.5%. Comparable to the result in 
the NegKCP-1 clone (Fig. 4.9 A), the shape of the response was also 
different. The signal took longer to develop and did not go back to basal levels 
after inhibition of PKC activity in NegKCP-1RR227/ 228 and in NegKCP-1. 
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Taken together, these experiments do not confirm any model, in which these 
particular amino acids in the PH domain and the acidic look are interacting 
with each other. 
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4.3 Effect of fluorophore dimerization on KCP-1 and KCP-2 
 
Most fluorescent proteins (FPs) are known to have the tendency to 
oligomerize271. The degree and stoichiometry, with which they oligomerize, 
vary from organism to organism. Fluorescent proteins from Aequorea victoria 
are the only ones that do not form obligate oligomers. These FPs form weak 
dimers196 (see Fig. 4.12). When measuring the interaction of tagged proteins 
with FRET, it is crucial that the reporter proteins do not in any way interfere 
with, or even create, an interaction. Effects due to dimerization of the FPs in 
the three-dimensional cytosol have not yet been shown, but it has been 
shown to create artifacts in membrane-protein systems270. 
There is a hydrophobic patch at the dimer interface that is thought to be 
responsible for the dimerization (Fig. 4.12 A, cyan box). Independent 
mutations of any of the three hydrophobic amino acids in this patch (Ala206, 
Leu221 and Phe223) to a lysine or an arginine greatly reduce the dimerization 
tendency. 
 
Fig. 4.12 Crystal structure of GFP 
A Crystal structure of GFP from Aequorea victoria196. Monomers of GFP form a head to tail 
dimer, but substitution of any of the three indicated residues with a positively charged amino 
acid reduces the molecule's tendency to dimerize. Ala206 is shown in red, Leu221 in blue and 
Phe223 in yellow. (PDB no 1GFL) 
B Enlarged picture of the three residues in the hydrophobic patch responsible for FP 
dimerization in A. victoria. 
 
While the dissociation constant (Kd) for the wild type protein is about 0.11 mM, 
it is 9.7 mM if Leu221 is mutated to lysine. The mutation A206K has the 
strongest effect, increasing the Kd to 74 mM. A reliable determination of this 
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value was however not possible due to the extreme monomeric nature of the 
protein270. 
We first introduced the A206K mutation into both, EYFP and GFP2, in KCP-1 
and KCP-2 probes, and then individually into one fluorophore at a time. 
Additionally, the L221K mutation was introduced into EYFP and GFP2, to 
study the effect of a lower dimerization tendency that is not entirely 
monomeric. Monomeric fluorophores were named "m" for monomeric, the 
L221K constructs were named m221 for distinction from the truly monomeric 
FPs. 
Fig. 4.13 Introduction of monomeric fluorescent proteins into KCP-1 
Mutations that decreased the proteins ability to dimerize were introduced into EYFP and GFP2 
of KCP-1. Experiments were performed in N1E cells on the Visitron system.  
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. While the original probe KCP-1 showed a clear increase in emission ratio upon 
stimulation with PMA, all probes containing one or more monomeric proteins displayed a 
small decrease in emission ratio.  
B Single cell examples from the experiments are color-coded according to FRET level. A 
distinctive color change, indicating a significant change in emission ratio of the probe, is seen 
only in the first panel showing the original KCP-1 probe. 
 
   
Results   81 
The effect of these mutations was very pronounced and consistent for all 
KCP-1 probes tested (Fig. 4.13 A). Irrespective of whether one or both 
fluorophores were monomeric, whether it was the strong monomeric mutation, 
A206K, or the weaker one, L221K, the EYFP/GFP2 emission ratio always 
decreased to 2.4-3.1%. The result was reproducible in signal amplitude and 
direction. 
Fig. 4.14 Introduction of monomeric fluorescent proteins into KCP-2 
Mutations that decrease the proteins ability to dimerize were introduced into EYFP and GFP2 
of KCP-2. Experiments were performed in N1E cells on the Visitron system.  
A PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. While the original probe, KCP-2, showed a significant decrease in emission ratio upon 
stimulation with PMA, all probes containing one or more monomeric proteins displayed only a 
minor decrease in emission ratio.  
B Single cell examples from the experiments are color-coded according to FRET level. A 
distinctive color change, indicating a significant change in emission ratio of the probe, is seen 
only in the first panel showing the original KCP-2 probe. 
 
A strong effect can also be observed in the KCP-2 probes carrying monomeric 
fluorescent proteins. In these experiments, the direction of the signal did not 
change compared to the original KCP-2 probe, but the amplitude was 
significantly smaller (Fig. 4.14 A). While the emission ratio in the original 
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probe decreased about 15% upon phosphorylation, the ratio in the monomeric 
probes only decreased to 6-6.4% of basal level. This corresponds to about 
42% of the response of the original probe. Again, this effect was independent 
of whether one or both of the fluorescent proteins were monomeric. 
 
To study whether our probes generally depended on the dimeric state of the 
fluorophores, or if this was only the case if using A. victoria FPs, we 
exchanged GFP2 and EYFP with monomeric FPs from Discosoma. These 
monomeric proteins were published at the end of 2004 and provided real 
monomers with good spectral properties from yellow to red210. We used 
mOrange as donor (replacing GFP2) and mCherry as acceptor (replacing 
EYFP) in KCP-1 and KCP-2. Previous experiments in the lab had shown that 
these FPs could be used as a FRET pair, although their FRET efficiency was 
lower in amplitude than that for EYFP/ECFP or EYFP/GFP2 (Alen Piljić, 
unpublished data). 
Fig. 4.15 KCP-1 and KCP-2 with monomeric FPs mCherry and mOrange 
A Normalized spectra of the excitation (dashed line) and the emission (solid line) of mOrange 
(green) and mCherry (red). 
B PKC activity was stimulated by addition of 200 nM PMA after 2.75 min and inhibited with 
Gö6983 after 10 min. The EYFP/GFP2 emission ratio of different probes was plotted against 
time. The monomeric probes with mOrange and mCherry displayed no change in emission 
ratio upon phosphorylation. 
Neither of the two probes with mCherry and mOrange showed any change in 
mCherry/mOrange emission ratio after PKC stimulation with PMA.  
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Taken together these experiments showed that dimerization of the 
fluorophores in pleckstrin-based PKC probes is crucial for good probe 
performance. Even though all monomeric or partly monomeric probes with 
fluorophores derived from A. victoria showed changes in emission ratio upon 
PKC phosphorylation, these changes were much smaller than in the original 
dimerizing probes. 
4.4 Summary of mutational data on KCP-1 and KCP-2 
 
The following table summarizes all results shown so far. The percentage of 
probe performance normalized to the respective KCP-1 or KCP-2 probe under 
same conditions is shown for each altered probe. 
KCP-1 derived probe % of the 
original 
signal 
KCP-2 derived probe % of the 
original 
signal 
3S KCP-1 103.52 3R KCP-2 104.49 
3R KCP-1 100.00 6S KCP-2 82.05 
6S KCP-1 38.73 6R KCP-2 78.85 
6R KCP-1 50.00 10S KCP-2 71.15 
10S KCP-1 2.11 10R KCP-2 65.38 
10R KCP-1 10.56   
12RS KCP-1 -2.11   
    
YFP∆8 KCP-1 65.63 YFP∆8 KCP-2 54.73 
PH∆7 KCP-1 -52.08 PH∆7 KCP-2 54.73 
    
NeutKCP-1 59.38 NeutKCP-2 58.11 
NegKCP-1 -104.17* NegKCP-2 78.38* 
NeutKCP-1RR227/228 27.08   
NeutKCP-1RRR232-234 58.33   
NegKCP-1RR227/228 -78.13*   
NegKCP-1RRR232-234* -28.13   
    
mYmG2KCP-1 -25.00 mYmG2KCP-2 40.54 
YmG2KCP-1 -32.29 YmG2KCP-2 43.24 
mYG2KCP-1 -27.08 mYG2KCP-2 40.54 
m221YG2KCP-1 -25.00 m221YG2KCP-2 43.24 
Table 4.2 Table summarizing the results for all mutations in KCP-1 and KCP-2 
described so far 
A * denotes probes in which the probes' performance is severely disturbed and reversibility of 
the signal is not given. The percentage of response from the original probe is therefore not 
described accurately.  
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4.5 FRET efficiency of selected constructs 
 
We have so far studied the change in emission ratio in different PKC probes 
using in vivo measurements. We observed an increase or decrease from a 
certain starting level of FRET, without really looking at absolute FRET 
efficiencies. In order to examine the effect that certain mutations have on the 
probe, we need to know whether FRET levels in different probes are similar or 
not. Introducing mutations might have led to changes in the architecture of the 
probe, which influenced the FRET efficiency. If there was no longer any FRET 
between the two fluorophores, it would explain the lack of changes in 
emission ratio. 
 
We determined FRET efficiencies with two different methods, acceptor photo 
bleaching (AccPB, 3.2.1.12) and trypsination experiments using a fluorimeter 
(3.2.1.13). 
In AccPB experiments, the donor is imaged at its excitation maximum before 
and after bleaching of the fluorophore. The FRET efficiency is calculated as 
the percentage of the total excitation energy transferred from donor to 
acceptor, as measured by the emitted fluorescence. 
The AccPB showed a clear change in FRET efficiency of KCP-1 and KCP-2 
after phosphorylation (Fig. 4.16 A). The unphosphorylated KCP-1 probe had a 
starting FRET level of 17%, which increased to 26% after phosphorylation. 
The unphosphorylated KCP-2 probe on the other hand, had a starting FRET 
level of 28.5% that decreased to 17% after phosphorylation. This is consistent 
with the live cell imaging data: the emission ratio of KCP-1 increased after 
phosphorylation, while it decreased in KCP-2 (Fig. 4.2 B). In all of the probes, 
that contained any of the monomeric mutations (A206K or L221K), in EYFP 
and/or GFP2, the FRET efficiency was between 13-21%. The changes seen, 
when going from the unphosphorylated to phosphorylated probe, where 
usually very small, with the FRET efficiency being slightly lower after PKC 
activation than before. This again, corresponded well with the live cell imaging 
data. 
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The AccPB data suggested that FRET still occurred in the monomeric probes, 
but the change upon phosphorylation was abolished by introducing the 
mutations. 
Fig. 4.16 Comparison of FRET efficiency as measured with acceptor photo bleaching 
A Comparison of FRET efficiencies of the original KCP-1 and KCP-2 probes and their 
monomeric or partly monomeric constructs, as measured with acceptor photo bleaching. 
B Comparison of FRET efficiencies of the original KCP-1 and KCP-2 probes and selected 
other constructs used in this thesis, as measured with acceptor photo bleaching. 
C Single cell examples of the original data from the acceptor photo bleaching experiments. 
FRET efficiency is shown before and after PKC stimulation in the two original probes KCP-1 
and KCP-2 and, as an example for all other samples, in the probes carrying the A206K 
mutation in both fluorophores, EYFP and GFP2. The level of FRET efficiency is color-coded, 
from blue (no FRET) to red (high FRET). 
 
We also determined the FRET efficiency of our other monomeric probes, 
mCherry-KCP-1-mOrange and mCherry-KCP-2-mOrange (Fig. 4.16 B). The 
FRET efficiency of mCherry-KCP-1-mOrange was very low, around 3% 
unphosphorylated and 0.5% after phosphorylation. The FRET efficiency of 
mCherry-KCP-2-mOrange was slightly higher, around 8% unphosphorylated 
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and 8.5% after phosphorylation. In both probes, FRET efficiency was rather 
low in the first place and it did not change much depending on the 
phosphorylation state. This explained the lack in any change of emission ratio 
in the probes (Fig. 4.15 B). 
The constructs that we used for discrimination of inter- versus intramolecular 
FRET all had very low levels of FRET efficiency, between 0.5 to 3.8% (Fig. 
4.16 B). This is not surprising as we did not expect those probes to exhibit 
FRET at all, since they should not be interacting closely. 
 
FRET efficiency was also measured with trypsination experiments (3.2.1.13). 
In these experiments, the acceptor was not bleached away as in AccPB, but 
removed by trypsin. Trypsin cleaved the probe, but left both fluorophores 
intact. The donor emission was measured in the fluorimeter before and after 
trypsin cleavage of the probe. The FRET efficiency was calculated as the 
percentage of the total excitation energy transferred from donor to acceptor, 
as measured by the emitted fluorescence. 
The trypsination experiments also showed a clear difference in the FRET 
efficiencies of KCP-1 and KCP-2, before and after phosphorylation (Fig. 4.17). 
The unphosphorylated KCP-1 probe had a starting FRET level of 16%, which 
increased to 20% after phosphorylation. The unphosphorylated KCP-2 probe, 
on the other hand, had a starting FRET level of 25.3% that decreased to 16% 
after phosphorylation. Again, this was in agreement with the live cell imaging 
data: the emission ratio of KCP-1 increased after phosphorylation while it 
decreased in KCP-2 (Fig. 4.2 B). 
While FRET efficiencies for KCP-1 and KCP-2 measured in trypsination or 
AccPB experiments compared well with each other, the results are less 
homogenous for the monomeric or partly monomeric EYFP/GFP2 samples. 
The measured FRET efficiency was between 2.3-5.6% for most KCP-1 
derived samples. For the m221YGKCP-1 probe, however, the result was over 
13%. In KCP-2 derived samples, the FRET efficiency varied from 4 to 10.5%. 
The FRET efficiency was usually lower after phosphorylation, as observed in 
the live cell experiments. Only in the mYGKCP-1 and mYGKCP-2 samples, 
did the apparent FRET efficiency increase after phosphorylation. 
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Fig. 4.17 Comparison of FRET efficiencies as measured with trypsination experiments 
Comparison of FRET efficiencies of the original KCP-1 and KCP-2 probes and monomeric or 
partly monomeric constructs, as measured with trypsination experiments. 
 
The FRET efficiencies determined by trypsination experiments for the 
monomeric probes using mCherry and mOrange were similar to those 
determined by AccPB: 2% for Ch-KCP-1-Or before and 0.5% after 
phosphorylation. It was slightly higher for Ch-KCP-2-Or with 4.1% before and 
4.8% after phosphorylation. 
Levels of calculated FRET efficiencies from trypsination experiments varied 
greatly and the error in FRET efficiencies was higher than if the values were 
determined by AccPB. Cell lysates are not the best environment for 
determination of FRET efficiencies as the cellular environment is too difficult 
to control. Other kinases and phosphatases might act on the probe as well as 
proteases. Determination of FRET efficiencies by trypsination is a very good 
method for purified samples, as there is no risk in bleaching the donor as well. 
Values might therefore be slightly more accurate than with AccPB. For a fast 
determination of many samples, however, AccPB is the faster and more 
reliable method. 
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4.6 Intra- versus intermolecular FRET in KCP-1 and KCP-2 
 
Since we showed that the dimerization state of the fluorophores used for PKC 
probes is very important, we had to consider the possibility of intermolecular 
FRET, as well as intramolecular FRET. Thus far, we have assumed that the 
FRET, measured in all KCP-1 and KCP-2 probes, stemmed from an energy 
transfer between GFP2 and EYFP within one protein. According to our 
hypothesis, a conformational change within the probe led to a change in 
FRET efficiency after PKC activation or inactivation. 
Knowing the importance of fluorophore dimerization for probe performance, 
another model is possible: in the unphosphorylated state, the fluorophores of 
different probe molecules might be in close enough proximity for FRET, due to 
their oligomerization tendency. Misleading effects in FRET probes, due to 
fluorescent protein dimerization, have been reported before270. 
Phosphorylation might then lead to a conformational change, which enhances 
the dimerization in neighboring molecules in KCP-1 probes, while it destroys it 
in KCP-2 probes. 
 
Discrimination between inter- and intramolecular FRET is possible using two 
different experimental set ups. Both follow the same reasoning: FRET 
between the two fluorescent proteins of one molecule has to be inhibited, 
while still allowing for FRET between fluorophores of different molecules. 
In the first experiment, we introduced an Y66S mutation into either EYFP or 
GFP2. Y66S is one of the core amino acids forming the fluorophore in FPs 
from A. victoria196. If it is replaced by non-aromatic amino acids, the FP is 
rendered non-fluorescent. 
Two altered constructs were co-transfected for each probe: one with a 
functional GFP2 but a non-fluorescent EYFP (EYFPY66S KCP-1 or 
EYFPY66S KCP-2), and the second one with a functional EYFP but a non-
fluorescent GFP2 (GFP2Y66S KCP-1 or GFP2Y66S KCP-2). This set up still 
allowed FRET between the functional GFP2 of one probe molecule and the 
fluorescent EYFP of another probe molecule, but not within the same probe 
(see schematic illustration Fig. 4.18 A). 
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Before each experiment with these constructs, expression levels of both 
proteins had to be checked. Both constructs have to be expressed at the 
same level to allow any statement about the change in FRET. As the original 
probes are stoichiometric probes, they were used as reference for equal 
expression levels. The individual fluorescence levels had to be determined 
individually for KCP-1 and KCP-2 individually as they have different basal 
FRET levels. 
The experiments were performed in HeLa and N1E cells, but a change in 
EYFP/ GFP2 emission ratio could not be observed in any experiment (Fig. 
4.18 B, blue and green line, imaged in HeLa cells), neither with KCP-1 nor 
with KCP-2. This indicated that intermolecular FRET was not occurring in this 
experiment. 
Fig. 4.18 Discrimination between inter- and intramolecular FRET in PKC probes 
A Schematic representation of the experiment: each molecule contained only one fluorescent 
protein, the second one was rendered non-fluorescent. This arrangement excludes any 
intramolecular FRET, while intermolecular FRET is still possible. 
B PKC activity was stimulated by addition of 200 nM PMA and inhibited with Gö6983 after 10 
min. The EYFP/GFP2 emission ratio of different probes was plotted against time. Both KCP-1 
(EYFPY66S KCP-1 and GFP2Y66S KCP-1) or both KCP-2 (EYFPY66S KCP-2 and 
GFP2Y66S KCP-2) constructs were co-transfected into HeLa cells and their signal compared 
to the original probes. While the original probes showed a clear signal, the co-transfected 
probes showed none.  
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In the second set of experiments, addressing the same question, we made 
probes that encode only on species of fluorescent protein. In one construct, 
the N-terminal EYFP was replaced by a second GFP2; in another construct, 
the C-terminal GFP2 was replaced by a second EYFP (see 3.2.2.4). Both 
constructs were co-transfected (EYFP-KCP-1-EYFP with GFP2-KCP-1-GFP2 
or EYFP-KCP-2-EYFP with GFP2-KCP-2-GFP2, respectively) into cells and 
the FRET ratio measured after stimulation of PKC activity. Again, this set up 
made FRET within one molecule impossible, while it was still possible 
between two different molecules (for a schematic illustration, see Fig. 4.19 A).  
As in the first experiments, care had to be taken to choose cells with equal 
expression levels of both constructs. 
Fig. 4.19 Discrimination between inter- and intramolecular FRET in PKC probes –part 2 
A Schematic representation of the experiment: each molecule contained two fluorescent 
proteins of the same kind. This arrangement excludes any intramolecular FRET, while 
intermolecular FRET is still possible. 
B PKC activity was stimulated by addition of 200 nM PMA and inhibited with Gö6983 after 10 
min. The EYFP/GFP2 emission ratio of different probes was plotted against time. Both KCP-1 
(EYFP-KCP-1-EYFP and GFP2-KCP-1-GFP2) or both KCP-2 (EYFP-KCP-2-EYFP and GFP2-
KCP-2-GFP2) constructs were transfected into HeLa cells and their signal compared to the 
original probes. While the original probes showed a clear signal, the co-transfected probes 
showed none. 
 
Experiments were performed in N1E and HeLa cells, but changes in emission 
ratio could be observed in neither (Fig. 4.19 B, green and blue line, imaged in 
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N1E cells). Again, this showed clearly that intramolecular FRET was not 
taking place. 
 
Together, these experiments demonstrated, that the effect observed in KCP-1 
and KCP-2 probes, is due to intramolecular FRET rather than intermolecular. 
Dimerization has effects within the probe, but that effect does not extend to 
other molecules.  
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4.7 Changing the FRET pair in PKC probes 
 
4.7.1 PKC probes using the AGT-labeling approach and chemically 
synthesized fluorophores 
 
Changing the FRET pair in our PKC probes has two main advantages: 
Firstly, it would aid multiparameter imaging. If we want to measure other 
parameters in a single experiment using other probes, they usually need to be 
in different wavelength areas of the visible spectrum. Many existing probes 
use ECFP/EYFP as a FRET pair, e.g. calcium sensors165,166, a cAMP 
sensor280 or in translocation and self-association assays of annexin 4 on 
membrane surfaces281. 
Secondly, shifting probes to higher excitation and emission wavelength not 
only aids multiparameter imaging, but also decreases the risk of 
photodamage. Imaging with red light would even allow imaging of tissue or 
whole animals, as it penetrates deeper than blue or green light and is less 
harmful. 
 
As it had been shown in a previous thesis from our lab282, combinations of 
other possible FRET pairs, using differently-colored genetically encoded 
fluorophores, yielded only weak probes (Cit-KCP-2-ECFP, Cit-KCP-2-mRFP). 
Mostly these probes failed to show any change in emission ratio at all (Cit-
KCP-1-ECFP, Cit-KCP-1-RFP). 
We therefore decided to use AGT labeling227,228. This technique is based on a 
genetically encoded tag that can be covalently labeled with small organic 
molecules inside living cells (Fig. 2.6). It enabled us to test a wide range of 
chemically synthesized fluorophores with different genetically encoded 
fluorescent proteins. 
ECFP and fluorescein (Fig. 4.20 A) have appropriate spectral properties to 
make FRET likely (Fig. 4.20 B): donor emission and acceptor excitation 
overlap well and both emissions are well separated. The O6-benzylguanine 
(BG) derivative of fluorescein-diacetate, BGAF, is readily hydrolyzed to BG-
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fluorescein (BGFL) by esterases within the cell and is known to label AGT 
efficiently in vivo228. 
 
Fig. 4.20 PKC probe using AGT labeled with fluorescein and ECFP 
A Chemical structure of O6-benzylguanine-fluorescein-diacetate and O6-benzylguanine-
fluorescein 
B Normalized spectra of the excitation (dashed line) and the emission (solid line) of ECFP 
(cyan) and fluorescein (green).  
C Cells were transfected with ECFP-KCP-1(or KCP-2)-AGT and labeled with fluorescein 
before the experiment. PKC activity was stimulated and subsequently inhibited with Gö6983. 
The emission ratio was measured over time. A small decrease in emission ratio upon 
phosphorylation and an apparent increase after Gö addition could be seen in both probes. 
D Same experiment as in C, however, the trace of non-transfected cells is included. It shows 
a huge increase in emission ratio in non-transfected cells due to addition of Gö6983.  
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Cell labeling with fluorescein in experiments using ECFP-KCP-1-AGT or 
ECFP-KCP-2-AGT worked well and the background to signal ratio was good. 
Stimulation of PKC activity with PMA led to a small decrease in emission ratio 
in both probes. Inhibition of PKC activity led to an increase in emission ratio 
that exceeded basal level (Fig. 4.20 C). 
As Gö6983 has a strong orange color, we had to examine whether it was 
influencing the signal. We analyzed a non-transfected cell that was adjacent 
to the transfected ones (Fig. 4.20 D). The trace in this experiment increased 
very strongly after PMA addition. The signal was clearly an artifact due to the 
color of the inhibitor itself, as no probe was present that could have detected 
any PKC activity. As fluorescein is not as bright as most genetically encoded 
FPs, the color of Gö6983 affected the signal more strongly than it did in the 
original probes. This effect had to be taken into account with all fluorophores, 
especially if they were further red-shifted than fluorescein, as most chemical 
fluorophores are not as bright as FPs. 
In addition, it was difficult to tell, whether the decrease in emission ratio after 
phosphorylation in the transfected cells was in fact due to any changes in the 
probe, or whether it was due to bleaching of the fluorescein. Fluorescein has a 
relatively high extinction coefficient (68.000 cm-1M-1, pH 8), a very good 
quantum yield (0.9) and is water soluble283, but it is not very photo-stable284. If 
the acceptor molecule pool decreased due to bleaching, it would also result in 
a decrease in the fluorescein/ECFP emission ratio. The signal to noise ratio in 
both traces (Fig. 4.20 C) was very bad compared to the original probes 
(compare Fig. 4.2 B). This also indicated that, if there was an actual signal, it 
was very weak and unreliable. 
 
In another set of experiments, we used Citrine202 (Cit) as a donor and a 
variety of red dyes as acceptor. These experiments were performed only in 
KCP-2 probes, as we had previously shown that KCP-1 is more sensitive to 
changes than KCP-2. 
Cy3 is a water soluble cyanine dye (Fig. 4.21 A), which is brighter and more 
photo-stable than fluorescein. This dye had to be microinjected as it is not 
cell-permeable. The emissions of Cit and Cy3 are nicely separated, although 
the excitation of Cy3 and the emission of Cit are not ideally suited for FRET 
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(Fig. 4.21 C). Cy 3 has a shoulder in its excitation spectra that falls within the 
excitation of Cit. We still thought it useful to test this pair as the cellular 
environment always influences the fluorophores and might enable FRET. 
Fig. 4.21 PKC probe using AGT with different labels and Citrine 
A Chemical structure of O6-benzylguanine-Cy3. 
B Chemical structure of O6-benzylguanine-SNARF-1. 
C Image of HEK-293 cells transfected with Cit-KCP-2-AGT and labeled with BG-SNARF. 
Excitation at 594 nm, emission measured from 600 to 660 nm.  
D Normalized spectra of the excitation (dashed line) and the emission (solid line) of Citrine 
(green), Cy3 (blue) and SNARF (red).  
E Cells were transfected with Cit-KCP-1(or KCP-2)-AGT and labeled with BG-Cy3 or BG-SNARF 
before the experiment. PKC activity was stimulated with PMA and the emission ratio was 
measured over time. No change in acceptor/donor emission ratio could be seen for any probe. 
 
Cells expressing Cit-KCP-2-AGT were microinjected with Cy3 and imaged 
after 90 min. Cy3 was excited at 561 nm to control labeling of AGT with the 
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dye. While the labeling worked well, no change in Cy3/Cit emission ratio could 
be observed after stimulation of PKC with PMA (Fig. 4.21 D, black line). 
In a second set of experiments the Cit-KCP-2-AGT construct expressed in 
HeLa cells was labeled with O6-benzylguanine-SNARF-1 (BG-SNARF, Fig. 
4.21 B). SNARF-1 is a long wavelength PH indicator developed by Molecular 
Probes283. Its excitation and emission maxima are quite broad, but Cit could 
be excited with 488 nm or 514 nm, where SNARF is only excited to a small 
extent (Fig. 4.21 C). 
No change in SNARF/Cit emission ratio could be observed after stimulation of 
PKC with PMA (Fig. 4.21 D, red line). 
 
One drawback in using AGT is the fact that it – being a full sized protein - is 
relatively large. We do not know in which orientation relative to the FP the 
fluorophore is bound to the AGT. It may be that the orientation was making 
FRET impossible, as the distance between the two fluorophores could be too 
large for FRET, or the transition dipole moments might not have been 
arranged in a suitable way. 
We tried to circumvent this problem, by using a shorter version of AGT228. 
AGT177 lacks the 28 C-terminal amino acids of the full length human AGT 
(207 amino acids285). These amino acids had previously shown not to be 
crucial for AGT activity286. We wanted to test whether the fluorophore in a 
shorter version of AGT, would be bound in a more favorable orientation for 
FRET with respect to the genetically encoded FP. 
As donor, we chose GFP2, as the clear separation between excitation and 
emission wavelength made exclusive donor excitation possible and reduced 
acceptor excitation significantly. 
The first FRET pair studied with the short AGT construct was GFP2 and O6-
benzylguanine-tetramethylrhodamine (BG-TMR, Fig. 4.22 A). TMR has an 
emission maximum at 553 nm and is more photo-stable than fluorescein. The 
overlap between donor emission and acceptor excitation is not very large, but 
FRET might still feasible as the donor could be excited without any acceptor 
excitation. In addition, the two emissions are nicely separated from each 
other, minimizing bleed-through of one emission into the other. 
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Fig. 4.22 PKC probe using AGT with different labels and GFP2 
A Chemical structure of O6-benzylguanine-tetramethylrhodamine (BG-TMR) 
B Chemical structure of O6-benzylguanine-2-OH-nile red (BG-NR) 
C Normalized spectra of the excitation (dashed line) and the emission (solid line) of GFP2 
(green), TMR (blue) and 2-OH-nile red (red). 
D Cells were transfected with GFP2-KCP2-1(or KCP-2)-AGT177 and labeled with BG-TMR or 
BG-NR before the experiment. PKC activity was stimulated with PMA and the emission ratio 
was measured over time. No change in acceptor/ donor emission ratio could be seen for any 
probe. 
 
After stimulation of PKC with PMA, no change in TMR/GFP2 emission ratio 
could be observed, neither in the KCP-1 derived sample nor in the KCP-2 
derived one (Fig. 4.22 D). 
 
The second dye used was O6-benzylguanine-2-OH-nile red (BG-NR, Fig. 4.22 
B), which was synthesized in our lab by Shannon Black. This dye has a broad 
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excitation band, which covers the emission range of GFP2 completely. Its 
emission is red shifted with a maximum at 633 nm (Fig. 4.22 C). 
Labeling with BG-NR worked inefficiently compared to the other dyes. The 
dye was cell permeable, but background labeling was high. In in vivo 
experiments, no change in NR/GFP2 emission ratio could be seen after 
stimulation of PKC with PMA, no matter whether the probe was KCP-1 or 
KCP-2 derived. 
Taking all experiments together, it did not seem likely that new PKC probes 
could be developed using the AGT-labeling technique. The dyes used in these 
experiments, with the exception of 2-OH Nilered, were all well established for 
AGT labeling. Cells without donor fluorescence never showed any acceptor 
fluorescence ruling out unspecific labeling. Unsuccessful labeling of the probe 
was therefore not expected and probe-intrinsic reasons were responsible for 
lack of probe performance. Measurements of absolute FRET efficiencies were 
not performed as no ratio change could be observed. 
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4.7.2 PKC probes using FlAsH and ECFP 
 
Another method of labeling proteins with chemically synthesized fluorophores 
is FlAsH labelling233,287. A short tetracysteine motif flanked by additional amino 
acids is introduced at the C- or N-terminus of the protein to be tagged and 
labeled with FlAsH-EDT2 (Fig. 4.23 A) before the experiment. 
We used an amino acid motif of 12 amino acids with the sequence 
FLNCCPGCCMEP, which has been shown to have higher fluorescence 
quantum yields and improved dithiol resistance compared to other 
tetracysteine motifs234. As a FRET partner for FlAsH, we chose ECFP. FRET 
between these two fluorophores has been previously used in a probe 
system178. Donor emission and acceptor excitation overlap nicely and both 
emission peaks are sufficiently well separated for ratiometric emission 
measurement (Fig. 4.23 A). 
We expected FRET between ECFP and FlAsH to be possible in our probes as 
FlAsH bound to the tetracysteine motif is much smaller than a second FP or 
AGT. This might facilitate a suitable orientation of both fluorophores, thereby 
allowing for FRET. We also used the monomeric version of ECFP, mCFP, as 
a donor for FlAsH. We did not expect to see differences in the probes using 
ECFP or mCFP, as dimerization is not expected to be of major importance in 
these probes. 
  
The FlAsH labeled KCP-1 probe only gave a small positive response after 
PKC stimulation. The original KCP-1 probe only showed an increase in 
EYFP/GFP2 emission ratio of about 3% in this particular microscope set up 
(Zeiss Axiovert 135), the mCFP-KCP-1-FlAsH FlAsH/ ECFP ratio increased 
by 6% (Fig. 4.23 B). The ECFP-KCP-1-FlAsH probe did not show a clear 
signal, but the ratio increased after addition of PMA and decreased after 
Gö6983 addition. Bleaching effects seemed much stronger for these probes. 
If cloned into the KCP-2 probe, the change in emission ratio was very strong 
after PKC activation (Fig. 4.23 D). Both samples, using ECFP or mCFP, 
showed a decrease of 18-20%, which is the same signal as for the original 
KCP-2 probe. The ECFP-KCP-2-FlAsH probe seemed slightly altered in its 
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kinetics and more affected by bleaching as the FRET level did not reach basal 
levels again. This effect was much smaller than in the corresponding KCP-1 
sample, though. 
  
Fig. 4.23 PKC probe using FlAsH and ECFP 
A Chemical structure of FlAsH-EDT2. 
B Normalized spectra of the excitation (dashed line) and the emission (solid line) of ECFP 
(cyan) and FlAsH (green). 
C Cells were transfected with ECFP(or mCFP)-KCP-1-FlAsH and labeled with FlAsH-EDT2 
before the experiment. PKC activity was stimulated with PMA and the FlAsH/ECFP (or 
mCFP) emission ratio was measured over time. Only a small change could be seen in the 
original probe and mCFP-KCP-1-FlAsH. 
D Cells were transfected with ECFP(mCFP)-KCP-2-FlAsH and labeled with FlAsH-EDT2 
before the experiment. PKC activity was stimulated with PMA and the FlAsH/ECFP (mCFP) 
emission ratio was measured over time. All probes show a clear response to phosphorylation. 
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We studied the FRET efficiency of the different FlAsH based probes by adding 
5 mM BAL (British-Anti-Lewisite, 2,3-dimercapto-1-propanol) to the 
experiment. BAL is a vicinal dithiol with a higher affinity for arsenicals than 
EDT or FlAsH. It strips FlAsH off the tetracysteine motif very effectively and 
leads to recovery of ECFP fluorescence236. 
This can clearly be seen by a very fast and steep decrease in FlAsH 
fluorescence emission accompanied by a simultaneous increase in ECFP 
fluorescence at the same time (Fig. 4.24 A). FRET efficiency is calculated as 
the quotient of the difference in ECFP fluorescence at the beginning of the 
experiment and after BAL treatment divided by the maximal fluorescence. The 
start value was taken just before addition of PMA, the maximal value after 
BAL addition when the curve had reached its maximum. 
 
Fig. 4.24 Measurement of FRET efficiency for FlAsH based PKC probes 
A Emission channels of EYFP and FlAsH during BAL treatment. 
B Comparison of FRET efficiencies determined after BAL addition to the experiment. 
 
Both KCP-1 derived probes had significantly lower FRET efficiency than the 
KCP-2 derived probes. The ECFP-KCP-1 probe had an efficiency of 18%, 
while the mCFP-KCP-1 probe had 19.5% (Fig. 4.24 B). For both samples, the 
error is very high, which corresponds to the results found during live cell 
experiments, where imaging proved more difficult than with KCP-2 samples. 
The difference in FRET efficiency between the monomeric and the dimerizing 
KCP-1-FlAsH probes was not significant. 
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The FRET efficiency in KCP-2-FlAsH probes showed at least double that of 
the efficiency in KCP-1-FlAsH probes. The ECFP-KCP-2-FlAsH probe had a 
FRET efficiency of 37.5%, while the monomeric version had 44.5% (Fig. 4.24 
B). The monomeric KCP-2-FlAsH probe had a 15% higher FRET efficiency 
than ECFP-KCP-2-FlAsH while the difference was only 8% in the monomeric 
KCP-1 FlAsH probe. 
The KCP-2 FlAsH probe is the first example of a FRET based probe 
combining FlAsH labeling with a genetically encoded fluorophore in the 
cytosol. We therefore named it KCP-F. KCP-F proves that background 
labeling of FlAsH in living cells can be small enough for background sensitive 
applications like FRET. This, however, requires careful optimization of labeling 
conditions. 
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5 Discussion 
 
5.1 Models showing the mechanism of action in KCP-1 and  
KCP-2 probes 
 
Based on the data collected in this work, we are able to present modified 
models for the mechanism of action of two previously published PKC probes, 
KCP-1 and KCP-2. 
Both models will be introduced at the beginning of this chapter and the 
implication of all results, in terms of these models, will be discussed 
subsequently. I will start with the model describing KCP-2. 
 
Fig. 5.1 Model for the mechanism of action of KCP-2 
A The unphosphorylated KCP-2 probe exhibits high FRET efficiency due to the dimerization 
of fluorophores, which pulls the probe to a more closed confirmation. Phosphorylation of the 
probe leads to stretching of the phosphorylation loop, resulting in lower FRET efficiency. 
B If dimerization is hindered, the fluorophores are further apart, even in the unphosphorylated 
probe, and KCP-2 exhibits lower FRET efficiency than before. Phosphorylation of the probe 
leads to stretching of the phosphorylation loop into the open conformation. As the initial 
distance was larger, the change in distance from phosphorylated to unphosphorylated is 
smaller. Hence, the change in emission ratio is smaller as well.  
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Unphosphorylated KCP-2 displays relatively high FRET efficiency. 
Phosphorylation of the probe through PKC leads to a decrease in FRET. NMR 
studies (unpublished data by Bernd Simon, Sattler group, EMBL Heidelberg) 
of the non-fluorophore-labeled pleckstrin insert of KCP-1, have shown that the 
unphosphorylated insert adopts a closed conformation (Fig. 5.2). 
 
Fig. 5.2 Closed structure of the pleckstrin insert 
NMR structure (Sattler group, EMBL Heidelberg) of the non-fluorophore labeled pleckstrin 
insert in the closed, unphosphorylated conformation. The PH domain is shown in red, the 
phosphorylation loop in yellow, the DEP domain in blue and the acidic loop in green. 
 
This conformation opens upon phosphorylation and the pleckstrin insert 
assumes a more stretched conformation. This leads to an increase in the 
distance between the PH and DEP domain, which in turn also increases the 
distance between the fluorophores. FRET data obtained with KCP-2 support 
these NMR data, as the FRET efficiency is reduced after phosphorylation. 
In this thesis, we have shown that there is an additional important element for 
good probe performance. Dimerization of fluorophores leads to a closer 
conformation of the domains than seen in the NMR data. According to the 
model proposed in this thesis, phosphorylation, and the subsequent 
conformational change in the phosphorylation loop, breaks the dimerization 
force, the probe opens up and adopts an open confirmation (Fig. 5.1 A). If we 
abolish the ability of the fluorophores to dimerize, they are already on average 
further apart in the initial conformation than in the original KCP-2 probe. The 
change in distance upon phosphorylation is therefore smaller, which results in 
a smaller change in the EYFP/GFP2 emission ratio. 
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Fig. 5.3 Model for the mechanism of action of KCP-1 
A Two forces determine the architecture of KCP-1, dimerization of the fluorophores and an 
interaction between the PH and the DEP domain. The second interaction leads to a different 
orientation of the fluorophores compared to KCP-2, resulting in lower FRET efficiency. 
Phosphorylation leads to a conformational change that rearranges the transition dipole 
moment of the fluorophores and leads to an increase in FRET efficiency. 
B If the PH-DEP interaction is disturbed (by changes in the PH domain), phosphorylation 
breaks the remaining dimerization force and the molecule opens up. This leads to reduced 
FRET efficiency after phosphorylation. 
C If the fluorophores are no longer able to dimerize, phosphorylation breaks the remaining 
PH-DEP interaction and the molecule opens up. This leads to reduced FRET efficiency after 
phosphorylation. The orientation of the transition dipole is indicated by an arrow in all models. 
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In our present model, fluorophore dimerization is only one of two forces 
determining the conformation of KCP-1 (Fig. 5.3 A). When imaging KCP-1 in 
living cells, we see an increase in FRET upon PKC activation. This indicates 
that the fluorophores are better positioned for FRET after phosphorylation 
than before, either due to distance or to relative orientation of the transition 
dipole moments. The only difference between KCP-1 and KCP-2 is the acidic 
loop of the DEP domain. We assume that this loop is responsible for the 
additional interaction, presumably by interacting with the PH domain (Fig. 5.3 
A). This PH-acidic loop interaction leads to a less favorable orientation of the 
transition dipole moments of the fluorophores, which results in lower initial 
FRET efficiency. Phosphorylation of the probe rearranges the structure of the 
phosphorylation loop, but it does not lead to a separation of fluorophores. 
Instead, the transition dipole moments of the fluorophores are changed to a 
more favorable orientation than in the unphosphorylated state. The force 
exerted by the phosphorylation is not enough to break the combined forces of 
dimerization and PH-DEP interaction. Instead, the force is deviated into 
rearranging the orientation of the fluorophores (Fig. 5.3 A). 
If one of the two interactions is missing in KCP-1, the phosphorylation-induced 
rearrangement is strong enough to break the remaining bond and the probe 
opens up resulting in a loss of FRET efficiency (Fig. 5.3 B and C). KCP-1 with 
only one intramolecular interaction (e.g. KCP-1 probes with monomeric 
fluorophores) behaves like KCP-2: the EYFP/GFP2 emission ratio decreases 
upon phosphorylation. 
5.2 Variations in the N-terminal linker region 
5.2.1 Additional amino acids in the N-terminal linker region  
 
Addition of amino acids in the N-terminal linker region has an impact on both 
probes, KCP-1 and KCP-2 (Fig. 4.3 and Fig. 4.4). In KCP-2, this is 
straightforward to explain. Increased linker length leads to an increase in the 
distance between the two fluorophores and thereby decreases initial FRET 
between them. The change in emission ratio after phosphorylation of the 
longer KCP-2 probes is still between 65-105% of the change in the original 
probe. The effect is relatively small as the dimerization of fluorophores still 
   
Discussion  107 
functions as a clamp, holding the FPs in a closed confirmation. If dimerization 
is hindered, on the other hand, the change in emission ratio of the monomeric 
probes is only 40-43% of the original probe (Fig. 4.14), showing the greater 
importance of dimerization as compared to linker length. 
The KCP-1 probe is more sensitive to additional linker length. Addition of ten 
amino acids leads to near abolishment of probe function, while KCP-2 still 
keeps 65% of its performance. KCP-1 is more sensitive to changes than KCP-
2, as two forces – dimerization and PH-DEP interaction - act on the probe. If 
additional amino acids are introduced in the linker region between EYFP and 
the pleckstrin insert, an additional strain is introduced. The additional amino 
acids have to be accomodated in the linker, leading to less ideal spacing of 
both interaction sites. This strain is stronger the more residues are added. 
There is an equilibrium between the functional and non-functional probes, 
where part of the molecules display the normal KCP-1 signal, while others do 
not. Introduction of three amino acids has no effect, while six additional 
residues already lead to a reduced probe performance of 40-50%. 
Introduction of more than six amino acids shifts the equilibrium towards the 
non-functional probes and the overall signal upon phosphorylation is even 
lower. If 12 residues are added, the strain on the both interactions upon 
phosphorylation is so strong that they brake apart in most probes. The signal 
of the probe reverses its amplitude and is now similar to KCP-2. 
Justin Brumbaugh performed similar experiments in the C-terminal linker 
region of KCP-12. He introduced a linker of 10 amino acids between the acidic 
loop and the C-terminal GFP2. These probes, however, displayed normal 
KCP-1 signals upon phosphorylation by PKC. Apparently, the C-terminal 
linker is flexible enough to allow for both interactions to still take place.  
5.2.2 Deletion of amino acids in the N-terminal linker region 
 
If additional amino acids influence the signal of KCP-1 and KCP-2 probes, 
shortening of the linker might also have an impact on probe performance. 
Deletion of residues at the C-terminus of EYFP leads to decreased probe 
performance in both probes (Fig. 4.6 and Fig. 4.7). YFP∆8KCP-1 still retains 
65% of the original performance, while YFP∆8KCP-2 retains 55%. We 
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suggest that reducing the linker at the end of EYFP has effects on the 
orientation of the fluorophores in both probes. The amino acids responsible for 
dimerization are located quite close to the C-terminus of the FP (A206, L221 and 
F223 in a protein of 239 residues). In order to still allow dimerization in the 
shorter probes, the angle of the FPs in relation to each other must change. 
Shortening the linker reduces the flexibility needed for dimerization and 
thereby changes the transition dipole moment in KCP-2 to a less favorable 
position and weakens the dimerization. Weaker dimerization shifts the 
equilibrium more towards the open conformation, which results in a smaller 
signal than in the original probe. 
In KCP-1, the additional strain introduced by shortening the probe leads to 
breakdown of both interactions in some molecules, reducing the ratio of 
functional to non-functional probes. The equilibrium, however, is still on the 
side of the functional molecules, leading to a probe performance that is still 
relatively high. This is similar to the results in probes with very long linkers. 
Deletion of the first seven amino acids of the PH domain has an effect on the 
function and structure of this domain. In KCP-1, it destroys one of the two 
crucial interactions: the PH-DEP interaction (Fig. 5.3 C). The probe now is 
similar to KCP-2 and the FRET ratio decreases upon phosphorylation. The 
initial FRET efficiency is higher in this probe compared with KCP-1 (Fig. 5.4), 
indicating that it is more similar to KCP-2. 
 
Fig. 5.4 Initial FRET efficiencies of KCP-1 and KCP-2 in comparison with KCP-1 probes 
that have a changed PH domain 
 
Besides disturbing the PH-DEP domain interaction, deletion of amino acids 
will also generally affect the PH domain and therefore lead to reduced probe 
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performance (Fig. 4.7 and Fig. 4.10). In particular, Arg7 might be crucial for 
the overall architecture of the PH domain as it is part of a β-sheet that 
interacts with an α-helix in the domain. Changes in the PH domain are likely to 
have effects, besides influencing the PH-DEP interaction. Firstly, the domain 
architecture is disturbed. The N-terminal PH domain of pleckstrin is known to 
be involved in both, protein-protein and protein-lipid interactions143,288-290. 
Changes in its architecture could therefore alter those interactions and lead to 
decreased phosphorylation of the probe. Secondly, the changed PH domain 
architecture will influence the orientation of the fluorophores to each other. 
These two effects, induced by changes in the PH domain, are also relevant 
KCP-2. In KCP-2, deleting the first seven amino acids of the PH domain leads 
to a signal similar to YFP∆8KCP-2. The N-terminal linker region of KCP-2, 
while less sensitive to elongations (Fig. 4.4 A), is relatively sensitive to 
shortening (Fig. 4.7 A). As discussed above, a possible explanation is that a 
longer linker is still flexible enough to allow proper dimerization in KCP-2, 
while a shortened linker reduces this flexibility. If the two molecules are not set 
correctly, the interaction is too loose and the resulting change in emission 
ratio is small (compare Fig. 5.1 B). It is important to note, however, that the 
major impact in PH∆7KCP-2, is the disturbance of the PH domain, not 
shortening of the linker. As will be discussed in the following paragraphs, the 
integrity of the PH domain is important also for proper performance in KCP-2 
probes. 
5.2.3 Changes in the charge distribution of the PH domain 
 
In our initial model, we assume that the interaction between the PH domain 
and acidic loop is based on charges. We suspected that aspartates and 
glutamates in the acidic loop were interacting with the basic residues at the 
start of the PH domain. In KCP-2, exchanging the basic residues with neutral 
ones (NeutKCP-2, Fig. 4.9 A), reduces the probe performance to 58% of the 
signal of the original probe. This is similar to the effect observed in the shorter 
probes, YFP∆8KCP-2 and PH∆7KCP-2, where the probes only exhibited 54% 
of the original signal. From our model for the mechanism of action of KCP-2, 
we would not expect large changes in the probe's performance when 
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introducing mutations in the PH domain, since we expect the mechanism to 
be independent of a PH-DEP interaction. We have to consider, however, that 
the overall architecture of the PH domain is disturbed, resulting in an altered 
orientation of the fluorophores. Introducing negative charges will disturb the 
domain architecture even more severely than introducing neutral residues. 
The EYFP/GFP2 emission ratio for NegKCP-2 decreases upon 
phosphorylation of the probe. The signal exhibits an apparent 78% of the 
original probe's performance, however, it does not go back to basal level after 
inhibition of PKC but stays at a significantly lower level. The fact, that the 
probe's performance is no longer reversible indicates severe changes have 
occurred in the overall architecture of the probe. 
In NeutPHKCP-1, the neutral amino acids have a similar effect as seen in the 
shorter probe, YFP∆8 KCP-1. The signal is decreased showing only 60% of 
the original KCP-1 signal. If the same amino acids are replaced with negative 
residues, the effect is much stronger. The signal reverses and shows a 
decrease in FRET ratio upon phosphorylation. This could be expected since 
we are destroying one of the two crucial interactions in KCP-1 (Fig. 5.3) and 
thereby making it more similar to KCP-2. We would also expect the initial 
FRET to be higher than in KCP-1, as the orientation of the fluorophores 
should be more KCP-2-like due to the disturbed PH-DEP interaction. Indeed, 
the initial FRET efficiency is higher in the NegKCP-1 probe, than in the 
original probe, reflecting an overall structure that is more similar to KCP-2. 
NegKCP-1 has a FRET efficiency that is 4 percentage points higher than the 
original probe. In YFP∆8KCP-1, the FRET efficiency is 2.5 percentage points 
higher (Fig. 5.4). Introducing neutral residues at the beginning of the PH 
domain has an effect on the architecture of the PH domain and will probably 
disturb the PH-DEP interaction. Introducing negative charges has a stronger 
effect, since they disturb this interaction even more severely. As in 
NegPHKCP-2, we see that the NegKCP-1 probe no longer reaches basal 
level anymore after inhibition of PKC activity. Again, the probes architecture 
seems to have been thoroughly disturbed. 
As we observed a big impact of negative charges on the probes performance, 
we tested whether it could be rescued by introducing positive charges in the 
acidic loop. If the probe depended on charge-charge interactions, this should 
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yield a functional KCP-1 probe. We created constructs that had positive 
charges in the acidic loop but negative charges in the PH domain. Fig. 4.11 A 
shows that the interaction between PH and DEP domain does not rely on this 
particular charge distribution. Using complementary charges (positive in acidic 
loop and negative in PH domain) did not re-establish the KCP-1 probe 
function. Instead, the neutral probes (NeutKCP-1RR227/228 and NeutKCP-
1RR232-234) gave a signal similar to NeutKCP-1, while the negative probes 
(NegKCP-1RR227/228 and NegKCP-1RR232-234) displayed a decrease in 
emission ratio comparable to NegKCP-1 (Fig. 4.11). Again, reversibility was 
not given anymore in the negative probes, showing the severe impact of the 
changes on the probe. The fact that the complementation probes were not 
able to rescue a KCP-1 like behavior rules out a simple charge-charge 
interaction. 
Fig. 5.5 Recent NMR structure of the DEP domain of human pleckstrin 
A Solution structure of human the DEP domain from human pleckstrin, solved by NMR 
(PDB no 1CSO by Yokoyama et al). Residues 221 to 229 are shown in red, residues F224 
and F225 are shown in blue and yellow (numbering according to numbering in this thesis).  
B Residues F224 and F225 were replaced by alanines. The response is a KCP-1 like 
response, if only F225A is present (red line), but it is KCP-2 like if F224A is introduced 
(black line). The response is also KCP-2 like, if both mutations are present in the molecule 
(green line). Experiments were performed by Justin Brumbaugh.  
  
A recent structure of the DEP domain has given important clues as to the 
nature of the PH-DEP interaction. The NMR structure of the DEP domain 
(PDB no 1CSO, to be published) was deposited in the protein data bank by S. 
Yokoyama et al (RIKEN Structural Genomics/Proteomics Initiative, Japan) in 
November 2005. The structure defines the DEP domain as slightly longer on 
both, the C- and N-termini, than the structure previously used by the Sattler 
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group (Fig. 5.2). Residues 221 to 229 are an integral part of the DEP domain, 
according to the more recent structure (see Fig. 5.5 A and B). 
Using the new NMR data, the structure of the closed pleckstrin insert could be 
re-calculated. The new calculations show that F225 interacts with a β-finger 
inside the DEP domain, while F224 packs into the PH domain. F224 is therefore 
likely to form part of the PH-DEP interaction in KCP-1 probes. This was 
confirmed by recent experiments in our lab (performed by Justin Brumbaugh). 
If F224 is mutated to alanine, the PH-DEP interaction is severely disturbed and 
the KCP-1 probe acts as a KCP-2 probe, exhibiting a negative change in 
emission ratio upon PKC activation (Fig. 5.5, black line). Mutation of F225 to 
alanine does not change the direction of the signal (Fig. 5.5, red line). 
Introduction of F224A inevitably leads to reversal of the signal, independent of 
whether F225 is mutated or not (Fig. 5.5, green line). These experiments 
identify residue F224 as crucial for determining the PH-DEP interaction in KCP-
1 and clearly show that it is not charge-charge but hydrophobic interactions, 
which are responsible for the PH-DEP interaction. While confirming the NMR 
data, they also explain why replacing the charges could not restore a KCP-1 
like signal. 
The NMR structure by Yokoyama et al also shows that residues after 229 are 
not important for the overall structure. Any changes after residue 229 are less 
likely to have a strong effect on KCP-1 probes, while changes before that 
residue will severely impair the interaction of the PH and DEP domain. This 
was confirmed by experiments performed in our lab, which showed that 
mutations or deletions of amino acids after 229 still yield a functional KCP-1 
probe (experiments performed by Justin Brumbaugh). It was also confirmed 
by the experiments using complementary charges in the acidic loop and the 
PH domain (Fig. 4.11 A). The direction of the signal is determined by whether 
the residues at the beginning of the PH domain are neutral or negative. 
Neutral residues will lead to a positive but reduced response upon 
phosphorylation as the architecture of the PH domain is slightly disturbed. 
Negative residues will lead to a negative response, as the PH domain, and 
therefore the PH-DEP domain interaction, is severely perturbed. The 
amplitude of the respective signals, however, is modulated by which amino 
acids in the acidic loop have been replaced by arginines. Replacement of 
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residues 232-234 has a less pronounced effect than replacement of residues 
227 and 228. This corresponds to the findings that amino acids after 229 are 
not crucial for DEP domain architecture, while those before 229 are essential. 
It is important to point out that the acidic loop is an intrinsic part of the DEP 
domain, not an additional feature of KCP-1. KCP-2 always has a disturbed 
PH-DEP domain interaction due to it having an incomplete DEP domain. 
5.3 Effect of fluorophore dimerization on KCP-1 and KCP-2 
 
The monomeric versions of both constructs show significantly reduced probe 
performance. Their signals are so weak that they are unsuitable for routine 
experiments. Monomeric KCP-1 samples show not only a decrease in signal 
amplitude but also a reversal of the signal direction upon phosphorylation. As 
illustrated in Fig. 5.1, the dimerization of the two fluorophores in KCP-2 
functions as a clamp, pulling them into a better orientation for FRET. If that 
interaction is missing, the fluorophores are on average further apart in the 
unphosphorylated state than they would be in the KCP-2 probe with 
dimerizing fluorophores. The change in distance upon going from the closed 
to the open conformation upon phosphorylation is not as pronounced 
anymore. 
In our model, dimerization is one of two forces determining the conformation 
of the probe molecule in KCP-1 (Fig. 5.3). The additional force in KCP-1, as 
compared to KCP-2, results in a different orientation of the fluorophores in the 
unphosphorylated probe. Subsequent phosphorylation does not lead to a 
greater distance between the fluorophores but to a rearrangement of the 
fluorophores resulting in a better orientation of the transition dipole and hence 
a higher FRET efficiency. If one of the two forces, e.g. dimerization or the PH-
DEP interaction, is broken, the probe behaves like KCP-2 and opens upon 
phosphorylation. 
It does not matter which of the fluorophores are monomeric, since the 
hydrophobic patch has to be present in both molecules for dimerization. 
Using other monomeric proteins, such as mCherry or mOrange (Fig. 4.15 B), 
is inefficient for the same reasons. Without the potential for dimerization, the 
probes could, at most, exhibit a very low FRET efficiency. Alen Piljić, in the 
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group, showed that the efficiency of mCherry and mOrange as a FRET pair is 
much smaller than ECFP/EYFP. While the FRET pair ECFP/EYFP in his 
assay displayed an emission change of a 150%281, the change was only 25-
30% when using mOrange/mCherry. These results indicate that the 
mCherry/mOrange FRET pair probably has a much smaller R0 than 
EYFP/ECFP. If we transpose this to the KCP probes, we would expect to see 
a signal, where the amplitude is about 1/5 of the signal for the monomeric 
probes. In KCP-1, this would mean a signal of about 0.5%, in KCP-2 a signal 
of about 1.2%. These signals are too small to be measured efficiently. It is 
therefore not surprising that we could not use the mOrange/mCherry FRET 
pair for this probe. 
5.4 FRET efficiency of selected constructs 
 
Comparing the results obtained in live cell imaging with the results from 
AccPB (Fig. 4.16 A) we have to conclude that there are limitations to the 
AccPB method when analyzing small changes in FRET efficiency. Although 
most of the monomeric probes show a slightly higher FRET efficiency before 
phosphorylation, the results are not as consistent as the live cell data. 
Phosphate groups are prone to detaching from the probe even if probes were 
measured on the same day. This leads to a higher observed FRET efficiency 
than we would expect in phosphorylated, monomeric probes. Experiments 
with KCP-1 and KCP-2 show the susceptibility of phosphates for detaching. If 
FRET efficiencies were measured on the same day, both original probes show 
clear differences in FRET efficiency, corresponding to the live cell 
experiments. If, however, the same sample was measured on the next day, 
we see a different result for both probes. The FRET efficiency of KCP-1 is 
smaller after phosphorylation than it used to be the day before. The FRET 
efficiency of phosphorylated KCP-2 is higher than it was the day before. Both 
of these results indicate that some of the phosphates have detached. As the 
changes, when going from the unphosphorylated to the phosphorylated 
probes, are much smaller in the monomeric constructs, they are more 
sensitive to this effect. 
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5.5 Intra- versus intermolecular FRET in KCP-1 and KCP-2 
 
Knowing the importance of fluorophore dimerization for probe performance, it 
was necessary to verify that FRET was taking place within the molecule and 
not with adjacent molecules. We could clearly show for the KCP probes, the 
FRET observed was a result of intramolecular and not intermolecular energy 
transfer. We set up two different experiments where FRET between 
fluorophores of one molecule was impossible but could still occur between 
FPs from different probe molecules. No change in FRET ratios could be 
detected upon phosphorylation, or subsequent dephosphorylation of the 
probes. The initial FRET efficiency in these probes was close to zero. 
Even though the possibility of intermolecular FRET had to be assessed, it is 
not very likely to take place. The fluorescent proteins from A. victoria form 
dimers, although relatively weak ones with a KD  of 0.11 mM270. It is plausible, 
that dimerization takes place within one molecule but it seems less likely to 
extend to other molecules as well. The fact that the dimerization force is 
overcome by phosphorylation is another indication of its relative weakness. 
 
5.6 Changing the FRET pair in PKC probes 
 
Changing the FRET pair in PKC probes is desirable for multiparameter 
imaging and wider application of the probe. As we have extensively discussed 
in the paragraphs above, dimerization is crucial for probe performance. 
Previous experiments in the lab282 had shown that a KCP-2 probe with ECFP 
and Citrine showed a reduced signal amplitude, while KCP-1 with ECFP and 
Citrine did not work at all. This was very surprising as these fluorophores are 
otherwise known to be a very good FRET pair. When designing FRET probes, 
it is desirable to have a large Förster radius for the FRET pair used. R0 for the 
EYFP and ECFP pair has been reported to be 4.92 nm, R0 for EYFP and 
GFP2 5.64 nm (R0 of EYFP/GFP2 was assumed to be the same as for 
EYFP/GFP as the donor emission/acceptor excitation overlap is the same)223. 
The difference in FRET efficiency at different distances for two Förster 
radiuses (4.9 corresponding to EYFP/ECFP and 5.6 corresponding 
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toEYFP/GFP2) has been plotted in Fig. 5.6. The reduced R0 explains the 
smaller signal in KCP-2, but not the lack in signal in KCP-1. It is likely that the 
transition dipole in ECFP is different from GFP2. This might result in a different 
rearrangement of the relative orientations after phosphorylation of the probe 
that is not favorable for FRET anymore. 
Fig. 5.6 Dependence of FRET efficiency for different R0 at distances from 1-10 nm 
 
While the difference in R0 for the two FRET pairs might not be crucial in other 
assays, it has a big impact in our PKC probes. We have previously seen that 
the probes are very sensitive to changes in their architecture and in the 
orientation of the fluorophores with respect to each other. It is therefore not 
surprising that they need a FRET pair with relatively high Förster radius. 
 
It is also not surprising that none of the probes combining AGT and a 
genetically encoded fluorophore yielded usable results. AGT with a bound 
fluorophore is only slightly smaller than GFP. The orientation of the chemical 
dye bound to AGT relative to the FP can vary greatly. It is not pulled in a 
closer orientation, as AGT cannot dimerize with FPs. The maximum response 
we could have expected, when using AGT labeled with a dye is about the 
same response as for the monomeric KCP-1 or KCP-2 probes. Even this 
result could only be observed if the dye were bound to AGT in a way that 
optimizes the relative orientation for the FP and the dye. This was obviously 
not the case, as we could not see any changes in emission ratio in the probes, 
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even when using ECFP and fluorescein, which are otherwise known to work 
as a FRET pair. 
 
The situation is different when looking at the FRET based probe based on 
ECFP and FlAsH. FlAsH, bound to the tetracysteine motif, is so small that 
dimerization no longer plays a role as it can get very close to the other 
fluorophore (Fig. 5.7). 
 
Fig. 5.7 Model for the mechanism of action on KCP-F 
Unphosphorylated KCP-F is in a closed conformation with high initial FRET efficiency. 
Phosphorylation of the probe by PKC leads to stretching of the pleckstrin insert and greater 
distance between the two fluorophores. The FRET efficiency therefore decreases. 
 
The PKC probe based on the FlAsH/ECFP FRET pair (KCP-F) is the first 
cytosolic FlAsH based FRET probe known so far. Only one other FRET probe 
using FlAsH has so far been published (Hoffmann et al178). This probe 
measures activation of G protein coupled receptors (GPCR) in living cells via 
FRET. FlAsH labeling has usually been used for the for the labeling of cellular 
substructures that have a very high concentration of tagged protein, e.g. 
connexins237, as this labeling is not generally very efficient. We have been 
able to show that using FlAsH is a valuable alternative to FP based FRET, 
even in a cytosolic environment. This is important for probe design, as the 
small size of FlAsH makes it a better label for most applications291. The study 
by C. Hoffmann et al178, also imaged GPCR activation using ECFP/EYFP as a 
FRET pair. This however, caused the downstream signaling to adenylyl 
cyclase to be perturbed. This problem was overcome by using the small 
tetracysteine tag and FlAsH. An additional advantage of FlAsH compared to 
FPs, is that it does not require any folding or maturation time. FP folding is not 
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instantaneous, which might influence the protein of interest even more than 
the size. This problem has, however, been greatly reduced in the new 
generation of fluorescent proteins. 
The reduced molecular size of KCP-F makes NMR analysis of the molecule 
possible. This will allow thorough understanding of the probe and will 
elucidate the probes' mechanism of action on a molecular level. This will be 
done in collaboration with M. Sattler at EMBL in Heidelberg. 
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6 Conclusions 
 
In the work presented in this thesis, we have investigated different aspects of 
protein kinase C probe performance. 
We were able to present improved models for the conformational switch of 
two previously published PKC probes, KCP-1 and KCP-2. In these models, 
we were able to demonstrate that dimerization of fluorophores can be used as 
a tool for increased probe performance. This is in contrast to the previously 
widely accepted view that fluorophore dimerization was a major caveat when 
using fluorescent proteins271. Dimerization can produce artifacts, but it can 
also be helpful for developing new probes. In our probes, no artifacts from 
dimerization were observed. Whether dimerization is foe or friend has to be 
individually decided for each application. 
Care has to be taken when influencing interactions within the probe molecule. 
In our probes, changes in the PH domain significantly affected probe 
performance, suggesting a previously undefined molecular interaction in the 
pleckstrin insert.  Intramolecular structures, stemming e.g. from the substrate, 
and their impact on probe performance have to be considered, but can also 
be used to obtain information about the substrate proteins' function. 
In addition, we demonstrated that linker length between the substrate loop for 
PKC phosphorylation and the N-terminal fluorophore determines good probe 
performance. While long linkers are too flexible for efficient energy transfer 
between two fluorophores, short linkers might be too stiff. This again, depends 
on the individual application and needs to be examined on a case by case 
basis. 
The newly developed FlAsH based FRET probe, KCP-F, proves that FlAsH 
labeling is a useful addition to the arsenal of FRET probes. Its small size, 
compared to FPs, make it less likely to interfere with protein function. The 
small size of the probe will permit structural analysis of the probe by NMR in 
the future. 
The resulting data will allow thorough understanding of the mechanism of 
action of pleckstrin-based PKC probes. Based on this information, existing 
probes might be improved and new probes developed. 
   
Outlook  120 
7 Outlook 
 
We were able to show that dimerization of the fluorophores is not per se a 
problem for probe development. In fact, it can be utilized to increase the signal 
amplitude by clamping the fluorophores in a favorable position for FRET. In 
our KCP-2 probe, for example, the initial FRET efficiency could be increased 
by 10% when using dimerizing fluorophores. This could be exploited in probes 
with weakly defined conformational changes locking either the initial or the 
final structure into a state where the fluorophores are in close proximity. In our 
case, we demonstrated that the concentration of the probes was not high 
enough to result in intramolecular FRET as a result of fluorophore 
dimerization. One should consider developing other molecular clamps to 
serve the same purpose. This would not be easy, however, as a balance has 
to be maintained with the interaction acting as a clamp but not dominating the 
protein structure. The weak dimerization of A. victoria FPs seems to be ideally 
suited for this purpose. 
Thus far, we have gathered a wealth of information about KCP-1 and KCP-2 
probes based on mutational analysis (1,2, this thesis and unpublished work by 
Justin Brumbaugh). An in depth understanding of the structure-activity 
relationship inevitably requires a high resolution structure. The KCP probes, 
containing two full sized FPs (27 kD each), are too big for NMR analysis. The 
newly developed KCP-F probe has a size more suited to NMR studies. The 
structure will be solved in collaboration with M. Sattler's group at EMBL, 
Heidelberg. This will allow comparison of the structural and mutational data. 
Combining structural and mutational data might facilitate the design of probe 
variants with greatly improved signal, which could then be suitable for high 
throughput screening for PKC inhibitors. 
Having established the feasibility of a FlAsH based probe opens the possibility 
of using EYFP and ReAsH has a FRET pair. This would be a first step 
towards shifting the probes emission to longer wavelengths. As mentioned 
previously, this is important for multiparameter and deep tissue imaging. 
Another approach would be to use other weakly dimeric FPs with different 
photophysical properties. 
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The spatial resolution of PKC signal detection could be increased even further 
by combing an EYFP/ReAsH probe with electron microscopy (EM). In a 
method developed by M. Ellisman's group237, proteins labeled with ReAsH 
could be used for photoconversion of diaminobenzidine (DAB). The dye-
catalyzed formation of singlet oxygen causes highly localized polymerization 
of DAB to an insoluble osmiophilic precipitate, visible by EM. 
There is indirect evidence282 that KCP-1 and CKAR, a PKC probe developed 
in R. Tsien's laboratory119, have differing isoenzymes specificity. This will be 
verified by using isoenzyme-specific inhibitors. Isoenzyme specific probes 
would be a valuable tool for elucidating the involvement of certain isoforms in 
specific pathways or different subcellular locations. It is likely that existing 
probes are phosphorylated by several PKCs but they might be able to be 
tailored towards greater specificity. 
The emission ratio in probes that had severely altered PH domains (NegKCP-
1 and NegKCP-2) did not return to basal levels after phosphorylation and 
subsequent dephosphorylation. The fact that reversibility is no longer given for 
some of the mutated probes could be exploited for the design of "memory 
probes". Rare transient phosphorylation/dephosphorylation events, for 
instance during the cell cycle, are hard to detect. A memory probe would 
retain the changed FRET efficiency after phosphorylation, even after the 
termination of the signal and subsequent dephosphorylation. This would be of 
particular interest in the study of transient signals, for example from Aurora 
kinases. 
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8 Appendix 
 
8.1 Primers used for cloning of constructs 
 
8.1.1 Variations in the N-terminal linker region 
 
a)  Additional amino acids in the N-terminal linker region 
 
Name  Target vector Sense primer Reverse primer 
3sKCP-1 KCP-1 KCP-1+3aa_s gKCP-1+3aa_rev 
6sKCP-1 KCP-1 KCP-1+6aa_s gKCP-1+6aa_rev 
10sKCP-1 KCP-1 KCP-1+10aa_s gKCP-1+10aa_rev
3rKCP-1 KCP-1 gKCP-1+3aa_rev KCP-1+3aa_s 
6rKCP-1 KCP-1 gKCP-1+6aa_rev KCP-1+6aa_s 
10rKCP-1 KCP-1 gKCP-1+10aa_rev KCP-1+10aa_s 
6r6sKCP-1 KCP1 gKCP-1+10aa_rev
KCP-1+10aa_s 
KCP-1+10aa_s 
gKCP-1+10aa_rev
6sKCP-2 KCP-2 KCP-1+6aa_s gKCP-1+6aa_rev 
10sKCP-2 KCP-2 KCP-1+10aa_s gKCP-1+10aa_rev
3rKCP-2 KCP-2 gKCP-1+3aa_rev KCP-1+3aa_s 
6rKCP-2 KCP-2 gKCP-1+6aa_rev KCP-1+6aa_s 
10rKCP-2 KCP-2 gKCP-1+10aa_rev KCP-1+10aa_s 
Table 8.1 Introduction of additional amino acids into KCP-1 and KCP-2 via 
oligonucleotide ligation 
 
b)  Deletion of amino acids in the N-terminal linker region 
 
Name  Template DNA Sense primer Reverse primer 
YFP∆8KCP-1 EYFP AgeI_YFP232_s BspEI_YFP232_rev 
YFP∆8KCP-2 EYFP AgeI_YFP232_s BspEI_YFP232_rev 
PH ∆7KCP-1 Pleckstrin insert BspEI-7aaPH_s BamHI-XaaPH_rev 
PH ∆7KCP-2 Pleckstrin insert BspEI-7aaPH_s 2BamHI-XaaPH2_rev 
Table 8.2 Overview of primers and template DNA for constructs with deletion of amino 
acids in the N-terminal linker of KCP-1 and KCP-2 
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c) Changes in the charge distribution of the PH domain 
 
Name  Template DNA Sense primer Reverse primer 
NegPHKCP-1 Pleckstrin insert 
KCP-1 
BspEI_neg_s BamHI-XaaPH_rev 
NegPHKCP-2 Pleckstrin insert 
KCP-2 
BspEI_neg_s 2BamHI-
XaaPH2_rev 
NeutPHKCP-1 Pleckstrin insert 
KCP-1 
BspEI_Neutr_s BamHI-XaaPH_rev 
NeutPHKCP-2 Pleckstrin insert 
KCP-2 
BspEI_Neutr_s 2BamHI-
XaaPH2_rev 
NegPHKCP1_DD KCP-1_DD227/228 BspEI_neg_s BamHI-XaaPH_rev 
NegPHKCP1_DDD KCP-1_DDD232-234 BspEI_neg_s 2BamHI-
XaaPH2_rev 
NeutPHKCP1_DD KCP-1_DD227/228 BspEI_Neutr_s BamHI-XaaPH_rev 
NeutPHKCP1_DDD KCP-1_DDD232-234 BspEI_Neutr_s 2BamHI-
XaaPH2_rev 
Table 8.3 Overview of primers and template DNA for constructs with changes in the 
charge distribution of amino acids in the N-terminal part of the PH domain of KCP-1 
and KCP-2 
8.1.2 Effect of fluorophore dimerization on KCP-1 and KCP-2 
 
Name  Template 
DNA 
Sense primer Reverse primer 
mGFP2 PCR1 GFP2 S1_GFP2_BamHI R2_A206K_rev 
mGFP2 PCR2 GFP2 S2_A206K_sense mGFP_XbaI_rev 
EYFP-dummy-mGFP2 PCR3 PCR 1/ 
PCR2 GFP2 
S1_GFP2_BamHI mGFP_XbaI_rev 
mYFP PCR1 EYFP mYFP_NheI_sense R2_A206K_rev 
mYFP PCR2 EYFP S2_A206K_sense mYFP_BsrGI_rev
mYFP-dummy-mGFP2 PCR3 PCR 1/ 
PCR2 YFP 
mYFP_NheI_sense mYFP_BsrGI_rev
m221GFP2 PCR1 GFP2 S1_GFP2_BamHI R2_L221K_rev 
m221GFP2 PCR2 GFP2 S2_L221K_sense mGFP_XbaI_rev 
YFP-dummy-m221GFP2 PCR3 PCR 1/ 
PCR2 GFP2 
S1_GFP2_BamHI mGFP_XbaI_rev 
m221YFP PCR1 EYFP mYFP_NheI_sense R2_L221K_rev 
m221YFP PCR2 EYFP S2_L221K_sense mYFP_BsrGI_rev
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m221YFP-dummy-m221GFP2 
PCR3 
PCR 1/ 
PCR2 YFP 
mYFP_NheI_sense mYFP_BsrGI_rev
Table 8.4 Overview of primers and template DNA for constructs with monomeric 
fluorophores in KCP-1 and KCP-2 
8.1.3 Intra- versus intermolecular FRET in PKC probes 
 
Name  Template DNA Sense primer Reverse primer 
Y66SYFP-KCP1-
GFP2 
KCP-1 T66S_YFP_sense T66S_YFP_rev 
Y66SYFP-KCP2-
GFP2 
KCP-2 T66S_YFP_sense T66S_YFP_rev 
EYFP-KCP1-
Y66SGFP2 
KCP-1 T66S_GFP2_sense T66S_ GFP2_rev 
EYFP-KCP2-
Y66SGFP2 
KCP-2 T66S_ 
GFP2_sense 
T66S_ GFP2_rev 
EYFP-dummy-EYFP EYFP-dummy-GFP2 + 
KCP-1 
S1_GFP2_BamHI mGFP_XbaI_rev 
GFP2-dummy-GFP2 EYFP-dummy-GFP2 mYFP_NheI_sense mYFP_BsrGI_rev
Table 8.5 Overview of primers and template DNA for constructs discriminating between 
intra- and intermolecular FRET 
 
8.1.4 Changing the FRET pair in PKC probes 
 
a) Clones using AGT and chemically synthesized fluorophores 
 
Name  Template 
DNA 
Sense primer Reverse primer 
ECFP-dummy-AGT pNuc-
GEhAGT-B 
BamHI-AGT-
GUT_sens 
AGT-TAA-XbaI reverse 
primer 
AGT177 PCR1 AGT177 S1_NheI-AGT R2_primer_AGT-BspEI 
AGT177 PCR2 AGT177 S2_primer-AGT-
BspEI 
R1_AGT-BspEI 
AGT177-dummy-GFP2 
PCR3 
AGT177 S1_NheI-AGT R1_AGT-BspEI 
AGT PCR1 AGT S1_NheI-AGT R2_primer_AGT-BspEI 
AGT PCR2 AGT S2_primer_AGT-
BspEI 
R1_AGT-BspEI 
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AGT-dummy-Cit2 
PCR3 
AGT S1_NheI-AGT R1_AGT-BspEI 
Cit-dummy-AGT AGT BamHI-AGT-
GUT_sens 
AGT-TAA-XbaI_rev 
Table 8.6 Overview of primers and template DNA for constructs using AGT and 
chemically synthesized fluorophore in KCP-1 and KCP-2 
 
b) PKC probes using FlAsH and cyan fluorescent protein 
 
Name  Target vector/ DNA Sense primer Reverse primer 
ECFP-KCP-1-FlAsH ECFP-KCP-1-AGT optFlAsH_sense optFlAsH_rev 
ECFP-KCP-2-FlAsH ECFP-KCP-2-AGT optFlAsH_sense optFlAsH_rev 
mCFP / PCR1 ECFP YFP_NheI_sense R2_A206K_rev 
mCFP / PCR2 ECFP S2_A206K_sense YFP_BsrGI_rev 
mCFP-KCP-1-FlAsH ECFP-KCP-1-AGT YFP_NheI_sense YFP_BsrGI_rev 
mCFP-KCP-2-FlAsH ECFP-KCP-2-AGT YFP_NheI_sense YFP_BsrGI_rev 
Table 8.7 Overview of primers and template DNA forKCP-1 and KCP-2 constructs 
designed for FlAsH labelling 
 
8.2 List of primers 
 
Name Sequence  
KCP-1+3aa_s 5'-CCGGTGCGG-3' 
KCP-1+6aa_s 5'-CCGGCGCCAACATCGTGT-3' 
KCP-1+10aa_s 5'-CCGGCATGTTCTCTATCAACC 
GCGTGTACG-3' 
gKCP-1+3aa_rev 5'-CCGGCCGCA-3' 
gKCP-1+6aa_rev 5'-CCGGACACGATGTTGGCG-3' 
gKCP-1+10aa_rev 5'-CCGGCGTACACGCGGTTGAT 
AGAGAACATG-3' 
AgeI_YFP232_s 5'-GTGACCGGTATGGTGAGCAAGGGC-3' 
BspEI_YFP232_rev 5'-GTATCCGGAAGTGATCCCGGCGGC-3' 
BamHI-XaaPH_rev 5'-CACGGATCCTTCTTTCAGAATCACATC-3' 
2BamHI-XaaPH2_rev 5'-CATGGATCCGTCTGGAAAGTAGTAG-3' 
BspEI_neg_s 5'-GACTCCGGAATGGAACCAGAGGAGATC 
GAAGAGGGCTACCTTGTG-3' 
BspEI_Neutr_s 5'-GACTCCGGAATGGAACCATTGCTGATCA 
GTGAGGGCTACCTTGTG-3' 
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S1_GFP2_BamHI 5'-GTAGGATCCATGGTGAGCAAGGGC-3' 
R2_A206K_rev 5'-GGGGTCTTTGCTCAGTTTGGACTG-3' 
mGFP_XbaI_rev 5'-TTGTCTAGATTACTTGGACAGCTCGT 
CC-3' 
S2_A206K_sense 5'-CAGTCCAAACTGAGCAAAGACCCC-3' 
mYFP_NheI_sense 5'-ACGGCTAGCATGGTGAGCAAGGGCG-3' 
mYFP_BsrGI_rev 5'-ACTTGTACAGCTCGTCCATGCCGAG-3' 
BamHI-AGT-GUT_sens 5'-ACGAAAGGATCCATGGACAAGGATT 
GTG-3' 
AGT-TAA-XbaI_rev 5'-TTGATTCTAGATTAGTTTCGGCCAGCA 
GG-3' 
S1_NheI-AGT 5'-TACCGCTAGCATGGACAAGGATTG-3' 
S2_primer_AGT-BspEI 5'-GGAGGTCCCGAGCCCCTGA-3' 
R1_AGT-BspEI 5'-GTTATCCGGAGTTTCGGCCAGCAG-3' 
R2_primer_AGT-BspEI 5'-TCAGGGGCTCGGGACCTCC-3' 
optFlAsH_sense 5'-GATCCTTCCTGAACTGCTGCCCCGGCT 
GCTGCATGGAGCCCTAAC-3' 
optFlAsH_rev 5'-CCGAGTTAGGGCTCCATGCAGCAGCCGG
GGCAGCAGTTCAGGAAG-3' 
T66S_YFP_sense 5'-CACCTTCGGCTCCGGCCTGCAG-3' 
T66S_YFP_rev 5'-CTGCAGGCCGGAGCCGAAGGTG-3' 
T66S_GFP2_sense 5'-CCCTGAGCTCCGGCGTGCAGTG-3' 
T66S_ GFP2_rev 5'-CACTGCACGCCGGAGCTCAGGG-3' 
Table 6.8.8  List of primers used for cloning of all constructs used in this thesis 
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8.3 Abbreviations 
 
AGT     human O6-alkylguanine-DNA alkyltransferase 
BG    O6-benzylguanine 
BGAF    O6-benzylguanine-fluorescein-diacetate 
BGFL    O6-benzylguanine-fluorescein 
BG-SNARF   O6-benzylguanine-SNARF-1 
BG-TMR   O6-benzylguanine-tetramethylrhodamine 
BSA     Bovine serum albumin 
CaMKII    Calcium/calmodulin dependent kinase II 
cAMP    Cyclic adenosine monophosphate 
CCD     Charge coupled device 
cGMP    Cyclic guanosinemonophosphate 
DAB    3,3'-diaminobenzidine  
DAG     Diacylglycerol 
DEP     Dishevelled, Egl-10, Pleckstrin 
dNTP     Deoxynucleotide triphosphate 
EBFP     Enhanced blue fluorescent protein 
ECFP    Enhanced cyan fluorescent protein 
EDTA    Ethylendiaminetetraacetic acid 
EGF     Epidermal growth factor 
EGFP    Enhanced green fluorescent protein 
EYFP     Enhanced yellow fluorescent protein 
EYF-KCP-1-EYFP  KCP-1 with N-and C-terminal EYFP 
EYF-KCP-2-EYFP  KCP-2 with N-and C-terminal EYFP 
EYFPY66S KCP-1  KCP-1 with non-fluorescent EYFP (Y66S mutation) 
EYFPY66S KCP-2  KCP-2 with non-fluorescent EYFP (Y66S mutation) 
FlAsH    Fluorescein arsenical hairpin binder 
FP     Fluorescent protein 
FRET     Fluorescence resonance energy transfer 
GFP     Green fluorescent protein 
GFP2     Green fluorescent protein square 
GFP2-KCP-1- GFP2  KCP-1 with N-and C-terminal GFP2 
GFP2-KCP-2- GFP2  KCP-2 with N-and C-terminal GFP2 
GFP2Y66S KCP-1  KCP-1 with non-fluorescent GFP2 (Y66S mutation) 
GFP2Y66S KCP-2  KCP-2 with non-fluorescent GFP2 (Y66S mutation) 
GPCR    G-protein coupled receptor 
Hepes    4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
IP3     Inositol 1,4,5-trisphosphate 
KCP-1    Protein kinase C probe 1 
KCP-2   Protein kinase C probe 2 
m221YG2KCP-1  KCP-1 with L221K mutation in EYFP and GFP2 
m221YG2KCP-2  KCP-2 with L221K mutation in EYFP and GFP2 
mCFP    Monomeric enhanced cyan fluorescent protein 
mCherry   Monomeric cherry (red fluorescent protein) 
mCh-KCP-1-mOr KCP-1 with mCherry as N-terminal fluorophore and 
mOrange as C-terminal fluorophore 
mCh-KCP-2-mOr KCP-2 with mCherry as N-terminal fluorophore and 
mOrange as C-terminal fluorophore 
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mGFP2   Monomeric green fluorescent protein square 
mOrange   Monomeric orange (orange fluorescent protein) 
MOPS    Morpholinepropanesulfonic acid 
mRFP    Monomeric red fluorescent protein 
mYFP    Monomeric enhanced yellow fluorescent protein 
mYG2KCP-1 KCP-1 with monomeric EYFP (A206K) 
mYG2KCP-2 KCP-2 with monomeric EYFP (A206K) 
mYmG2KCP-1 KCP-1 with monomeric EYFP and monomeric 
GFP2 (A206K in both) 
mYmG2KCP-2 KCP-2 with monomeric EYFP and monomeric 
GFP2 (A206K in both) 
NegKCP-1 KCP-1 with three negative amino acids in the PH 
domain 
NegKCP-1-RR227/228 KCP-1 with three negative amino acids in the PH 
domain and two basic ones in the acidic loop 
NegKCP-1-RRR232-234 KCP-1 with three negative amino acids in the PH 
domain and three basic ones in the acidic loop 
NegKCP-2 KCP-2 with three negative amino acids in the PH 
domain 
NeutKCP-1 KCP-1 with three neutral amino acids in the PH 
domain 
NeutKCP-1-RR227/228 KCP-1 with three neutral amino acids in the PH 
domain and two basic ones in the acidic loop 
NeutKCP-1-RRR232-234 KCP-1 with three neutral amino acids in the PH 
domain and three basic ones in the acidic loop 
NeutKCP-2 KCP-2 with three neutral amino acids in the PH 
domain 
PA    Phosphatidic acid 
PAGE    Polyacrylamide gel electrophoresis 
PAP    Phosphohydrolase 
PC     Phosphatidylcholine 
PCR     Polymerase chain reaction 
PDK-1    Phosphoinositol dependent kinase 1 
PH     Pleckstrin homology 
PIP2     Phosphatidylinositol 4,5-bisphosphate 
PKA     cAMP-dependant protein kinase 
PKB  Protein kinase B, also known as RAC (related to 
PKA and PKC) and Akt1 
PKC  Ca2+ activated, phospholipids-dependent protein 
kinase 
PKD     Protein kinase D 
PKG     cGMP-dependant protein kinase 
PKM     Catalytic subunit of protein kinase C 
PLC     Phospholipase C 
PLD    Phospholipase D 
PMA     4-12-O-Tetradecanoylphorbol 13-acetate 
PMT     Photo multiplier tube 
PS    Phosphatidylserine 
PTP1B    Phosphotyrosinephosphatase 1B 
RACK    Receptor for activated C kinase 
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ROI     Region of interest 
RTK    Receptor tyrosine kinase 
T4-PNK    T4-polynucleotide kinase 
TPA     4-12-O-Tetradecanoylphorbol 13-acetate 
YGY66S KCP-1 Co-transfection of EYFPY66S KCP-1 and 
GFP2Y66S KCP-1 
YGY66S KCP-2 Co-transfection of EYFPY66S KCP-2 and 
GFP2Y66S KCP-2 
YYGG KCP-1 Co-transfection of EYF-KCP-1-EYFP and GFP2-
KCP-1- GFP2 
YYGG KCP-2 Co-transfection of EYF-KCP-2-EYFP and GFP2-
KCP-2- GFP2 
YmG2KCP-1   KCP-1 with monomeric GFP2 (A206K) 
YmG2KCP-2   KCP-2 with monomeric GFP2 (A206K) 
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